{"meta":{"query_hash":"d3462be9f624","filters":{"venue":"Expert Review of Clinical Pharmacology"},"cohort_total":70,"direct_labels_cover":2,"predictions_cover":70,"exported":70,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d3462be9f624","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Review+of+Clinical+Pharmacology"},"results":[{"id":"W1974375960","doi":"10.1586/17512433.2013.811831","title":"Gram-negative superbugs: inappropriate antimicrobial therapy and mortality","year":2013,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Medicine; Antimicrobial; Intensive care medicine; Drug resistance; Antibiotic resistance; Antimicrobial drug; Pharmacotherapy; Anti-Infective Agents; Immunology; Antibiotics; Microbiology; Internal medicine; Biology","score_opus":0.04156694133645708,"score_gpt":0.4392310278738546,"score_spread":0.3976640865373975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974375960","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10528426,0.11978281,0.00002811742,0.0004737697,0.772163,0.0016935884,0.00021501661,0.00002005073,0.00033938774],"genre_scores_gemma":[0.0008423867,0.60843474,0.0007850362,0.0022850398,0.38689414,0.000052065207,0.0004220189,0.000051174575,0.00023342301],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994967,0.0012366293,0.0020168212,0.0010515505,0.00032607967,0.0004019399],"domain_scores_gemma":[0.9967505,0.00063175923,0.0011681886,0.0006489296,0.00060499535,0.00019566558],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016046914,0.0005360671,0.0020345028,0.00003424208,0.000056100653,0.00001977318,0.0006668706,0.0015035413,0.00041529222],"category_scores_gemma":[0.0024398514,0.00042588185,0.00053647166,0.000083285006,0.0010708721,0.000009824127,0.0003742633,0.0008192566,0.000023436833],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027267143,0.00025006107,0.0004480511,0.0019986464,0.0006046256,0.000005813337,0.000012540322,3.3571553e-8,0.017943872,0.0000021938504,0.9732034,0.005258073],"study_design_scores_gemma":[0.0016244914,0.0005644094,0.0011659208,0.0013503862,0.00012285121,0.0000024402063,0.000003979044,0.00000137821,0.008757399,0.00001821559,0.985954,0.00043451574],"about_ca_topic_score_codex":0.00008262339,"about_ca_topic_score_gemma":0.000005603777,"teacher_disagreement_score":0.4886519,"about_ca_system_score_codex":0.00001593481,"about_ca_system_score_gemma":0.0005292604,"threshold_uncertainty_score":0.9998193},"labels":[],"label_agreement":null},{"id":"W1983885439","doi":"10.1586/ecp.10.49","title":"Advances in oral anticoagulants: focus on dabigatran etexilate","year":2010,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabigatran; Medicine; Intensive care medicine; Rivaroxaban; Pharmacology; Atrial fibrillation; Warfarin; Internal medicine","score_opus":0.13370751864452812,"score_gpt":0.5562791191571606,"score_spread":0.42257160051263243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983885439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5756594,0.18105832,0.00013168869,0.14453097,0.03025336,0.0051782266,0.000012606967,0.00022130457,0.062954165],"genre_scores_gemma":[0.572254,0.40545425,0.0013152998,0.017430233,0.0032925361,0.000010333679,0.000012092485,0.000018789273,0.000212473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978871,0.00022567878,0.0012317289,0.00027027674,0.00019001786,0.0001952281],"domain_scores_gemma":[0.99861807,0.0007061131,0.00028460255,0.00021070908,0.00005830051,0.00012219754],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011943652,0.00014085125,0.0011867868,0.00008002009,0.000017614577,0.000002062204,0.00013151974,0.00011800942,0.0017017623],"category_scores_gemma":[0.00084290013,0.00009972115,0.0003305086,0.00018136404,0.00015723288,0.0000881283,0.00004269114,0.00042307764,0.00009187331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012015118,0.00026342293,0.16662794,0.0022861653,0.00012711635,0.00011014906,0.000033985296,0.0000021097228,0.00866186,0.0016386025,0.022494739,0.7965524],"study_design_scores_gemma":[0.0040415465,0.0005266409,0.053537805,0.0012098108,0.00012960815,0.000007411131,0.000005258064,0.00007360641,0.0023505606,0.00026604417,0.9377012,0.00015047632],"about_ca_topic_score_codex":0.0000050405524,"about_ca_topic_score_gemma":0.0000066793746,"teacher_disagreement_score":0.9152065,"about_ca_system_score_codex":0.000007103351,"about_ca_system_score_gemma":0.00004875401,"threshold_uncertainty_score":0.99921083},"labels":[],"label_agreement":null},{"id":"W1989316273","doi":"10.1586/ecp.12.72","title":"Current issues in biowaivers and biosimilars","year":2013,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Protein purification and stability","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biosimilar; Medicine; Library science; Family medicine; Internal medicine","score_opus":0.04851537287578259,"score_gpt":0.48056864695647394,"score_spread":0.43205327408069133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989316273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15736301,0.82368517,0.00004516738,0.016647091,0.001004227,0.0009093521,0.0000062867466,0.0000076420465,0.00033204583],"genre_scores_gemma":[0.14232819,0.8468283,0.0005631886,0.009805113,0.00030653377,0.0001184416,0.000017029826,0.000006084543,0.00002710773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985276,0.00035567107,0.0006470655,0.00028463482,0.000060190367,0.00012488132],"domain_scores_gemma":[0.99944526,0.00005579484,0.00014228922,0.00018367895,0.00008401126,0.0000889511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006572385,0.00009114349,0.00034226943,0.000020314068,0.00001286643,0.0000024505089,0.00014760917,0.00009062301,0.00048265187],"category_scores_gemma":[0.00042480996,0.00007445131,0.00009696609,0.000060731847,0.00023504783,0.000004331695,0.00008810149,0.000117297546,0.000017683169],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007642452,0.0006873738,0.024057532,0.0014624662,0.000055616016,0.0000012184364,0.000034626075,2.0187152e-7,0.07834568,0.000052322506,0.41204363,0.4831829],"study_design_scores_gemma":[0.0005518783,0.00013100379,0.019000461,0.00018685669,0.0000072058397,9.961066e-7,0.0000073485844,0.00001469807,0.012614651,0.000051595576,0.9673369,0.00009644064],"about_ca_topic_score_codex":0.000010682376,"about_ca_topic_score_gemma":0.0000018043224,"teacher_disagreement_score":0.55529326,"about_ca_system_score_codex":0.000003971867,"about_ca_system_score_gemma":0.000045924135,"threshold_uncertainty_score":0.52847},"labels":[],"label_agreement":null},{"id":"W1994783490","doi":"10.1586/ecp.09.37","title":"Transdermal contraceptive patches: current status and future potential","year":2009,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transdermal patch; Pill; Bust; Transdermal; Dosing; Venous thromboembolism; Boom; Pharmacology; Surgery; Thrombosis","score_opus":0.04731593212537507,"score_gpt":0.49519299677766454,"score_spread":0.4478770646522895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994783490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12233867,0.79627854,0.00024829016,0.07419474,0.0046387874,0.0017479431,0.000009922769,0.000041460495,0.0005016875],"genre_scores_gemma":[0.21098232,0.7537637,0.00032680348,0.024516175,0.010326162,0.000033987595,0.000020191139,0.000008243136,0.000022427419],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997336,0.00045224052,0.0012193667,0.00044452603,0.00020636976,0.0003415435],"domain_scores_gemma":[0.9987053,0.00013018608,0.00032222498,0.00018202553,0.00025612125,0.0004041126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008692857,0.00017728763,0.0011191797,0.0000372651,0.000042358053,0.000002381876,0.00006154784,0.00013854662,0.00074891886],"category_scores_gemma":[0.00018276474,0.00013149259,0.0002910665,0.00009875345,0.0001991005,0.00007972089,0.0000113600045,0.000547495,0.000013821928],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011922893,0.000769235,0.0006842978,0.001478337,0.00006167472,0.000017460039,0.00015058795,7.054565e-8,0.0025273222,0.0000563203,0.028675089,0.9643873],"study_design_scores_gemma":[0.004874463,0.0017698616,0.13858552,0.0009573772,0.0002852084,0.000039961393,0.00006632326,0.000028018592,0.00036533945,0.00006114092,0.8528189,0.00014786683],"about_ca_topic_score_codex":0.0000040534783,"about_ca_topic_score_gemma":2.7233963e-7,"teacher_disagreement_score":0.9642395,"about_ca_system_score_codex":0.000020743391,"about_ca_system_score_gemma":0.00022240274,"threshold_uncertainty_score":0.8200136},"labels":[],"label_agreement":null},{"id":"W1994861629","doi":"10.1586/ecp.09.62","title":"Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies","year":2010,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Endocannabinoid system; Synthetic cannabinoids; Medicine; Cannabinoid receptor; Cannabis sativa; Pharmacology; Cannabinoid; Effects of cannabis; Neuroscience; Bioinformatics; Cannabis; Cannabidiol; Biology; Receptor; Internal medicine; Psychiatry","score_opus":0.036792649526553964,"score_gpt":0.46066594782908776,"score_spread":0.4238732983025338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994861629","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041126326,0.5295928,0.0021217035,0.38593146,0.024470668,0.012890415,0.00017785795,0.00033920456,0.0033495482],"genre_scores_gemma":[0.71008664,0.12202424,0.0055762758,0.07366864,0.07946166,0.0055266875,0.00024344854,0.000250743,0.003161694],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704015,0.0004165595,0.0013071717,0.00040551584,0.0003595128,0.00047108],"domain_scores_gemma":[0.9978492,0.00036819663,0.0004129541,0.0004057662,0.0006396291,0.0003242266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020067368,0.0002294335,0.001047724,0.00004202411,0.00014024987,0.000018436134,0.00041123063,0.00010066548,0.0007856797],"category_scores_gemma":[0.0007884101,0.00012784162,0.00072346884,0.00017444066,0.00055202376,0.00006780434,0.00008668942,0.00092193246,0.00001388094],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008313775,0.0005182828,0.0010255462,0.011607386,0.00018025738,0.000044635086,0.00004855717,0.0000010527044,0.045862272,0.0021248618,0.89831734,0.03943843],"study_design_scores_gemma":[0.0022415842,0.001027761,0.0027136463,0.0012909605,0.00031745582,0.000261266,0.00073843065,0.00025612203,0.0009193087,0.000040955285,0.9900377,0.0001548268],"about_ca_topic_score_codex":0.000011807936,"about_ca_topic_score_gemma":0.0000017660342,"teacher_disagreement_score":0.6689603,"about_ca_system_score_codex":0.000026883246,"about_ca_system_score_gemma":0.0009377728,"threshold_uncertainty_score":0.8602641},"labels":[],"label_agreement":null},{"id":"W2005759075","doi":"10.1586/17512433.2013.842465","title":"Optimizing glycemic control: lixisenatide and basal insulin in combination therapy for the treatment of Type 2 diabetes mellitus","year":2013,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Medicine; Glycemic; Lixisenatide; Postprandial; Internal medicine; Hypoglycemia; Type 2 Diabetes Mellitus; Endocrinology; Basal (medicine); Diabetes mellitus; Insulin; Type 2 diabetes; Basal insulin","score_opus":0.0986510902370301,"score_gpt":0.47317738335092646,"score_spread":0.37452629311389635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005759075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023215107,0.9879786,0.000010186202,0.0011360969,0.0012346396,0.009298154,0.000014300032,0.0000129128575,0.00008296092],"genre_scores_gemma":[0.00006686674,0.9941226,0.0007127488,0.002243041,0.00041833648,0.0021850842,0.000110389374,0.0000410522,0.00009984893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965608,0.0005168599,0.0021009112,0.00039854922,0.00015348132,0.0002693593],"domain_scores_gemma":[0.9936833,0.0047021494,0.0010311648,0.0003097601,0.00017638842,0.00009727235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087076216,0.00039173377,0.004409742,0.00012713937,0.000024756,0.0000050648505,0.00017729065,0.00021759588,0.000181503],"category_scores_gemma":[0.0002567016,0.00020704596,0.0008215146,0.00019929095,0.00022178132,0.000041458272,0.000034443674,0.00017367784,0.000007828717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026984172,0.0017274629,0.000027735723,0.021558717,0.0017597211,0.0000024062574,0.000030446765,2.3826408e-7,0.0000031506609,0.000025336687,0.0050350265,0.9695599],"study_design_scores_gemma":[0.010491853,0.005437421,0.000028734223,0.015383128,0.0026775445,5.2307047e-7,0.000003933287,0.00017101904,0.000020412463,0.000017259883,0.96562445,0.00014369145],"about_ca_topic_score_codex":0.00000946644,"about_ca_topic_score_gemma":6.102166e-7,"teacher_disagreement_score":0.9694162,"about_ca_system_score_codex":0.000080728714,"about_ca_system_score_gemma":0.00016792066,"threshold_uncertainty_score":0.8443089},"labels":[],"label_agreement":null},{"id":"W2015413562","doi":"10.1586/ecp.12.32","title":"Clinical pharmacology confounders in older adults","year":2012,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Confounding; Intensive care medicine; Disease; Psychological intervention; Clinical pharmacology; Drug; Quality of life (healthcare); Pharmacotherapy; Adverse effect; Population; Health care; Pharmacology; Internal medicine; Psychiatry; Environmental health","score_opus":0.6626429988281188,"score_gpt":0.6641739356241866,"score_spread":0.00153093679606775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015413562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022497867,0.9451541,0.00007554449,0.009856446,0.0363036,0.0056738164,0.00022784602,0.000058192392,0.0026279653],"genre_scores_gemma":[0.000017113978,0.88792413,0.00079135667,0.09706128,0.012330616,0.001249958,0.00019838454,0.00013480404,0.0002923321],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.944408,0.010938639,0.04129426,0.0019067043,0.00020519122,0.0012471928],"domain_scores_gemma":[0.95831233,0.01972184,0.01982588,0.0010588143,0.00019949643,0.0008816133],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.08073161,0.0009677912,0.020393906,0.0006343203,0.000086634376,0.00001625117,0.0016226142,0.0018618065,0.016168084],"category_scores_gemma":[0.008017179,0.0010095175,0.0032883629,0.0005963712,0.00081241305,0.00039010326,0.00039390026,0.0025463114,0.007177924],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042845775,0.001449744,0.00080764963,0.14484286,0.000768575,0.000011528907,0.0001264806,1.980941e-7,8.145849e-9,0.00087199203,0.54427785,0.30680025],"study_design_scores_gemma":[0.0029174336,0.00017882172,0.00029407008,0.036861192,0.00041335128,0.000019058738,0.000032986485,0.00003428515,4.7144447e-8,0.000077508776,0.9583812,0.000790048],"about_ca_topic_score_codex":0.00017208622,"about_ca_topic_score_gemma":0.000018391973,"teacher_disagreement_score":0.41410333,"about_ca_system_score_codex":0.0005649308,"about_ca_system_score_gemma":0.0014159918,"threshold_uncertainty_score":0.99975485},"labels":[],"label_agreement":null},{"id":"W2021129775","doi":"10.1586/17512433.2.1.9","title":"Transitioning biomarkers into the clinic","year":2008,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical pharmacology; Editorial board; Medicine; Pharmacology; Library science","score_opus":0.10363176507144017,"score_gpt":0.5089950535381991,"score_spread":0.4053632884667589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021129775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16436163,0.740129,0.000040632367,0.071483664,0.0040120888,0.0014200046,0.0000035974167,0.000056443772,0.018492939],"genre_scores_gemma":[0.23143409,0.72666055,0.00061086623,0.039776135,0.0010054556,0.00012971554,0.000007304262,0.000011115494,0.00036478648],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980744,0.00030857703,0.0010473748,0.00023943097,0.00017047227,0.00015972703],"domain_scores_gemma":[0.9984996,0.000868866,0.00021909941,0.00018002676,0.00013035588,0.00010206553],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007878767,0.00012964745,0.00090964197,0.000023085238,0.00013913002,8.6660384e-7,0.00010830282,0.00006639956,0.0023272457],"category_scores_gemma":[0.00033412,0.00007093688,0.0005219784,0.00016807874,0.0006147833,0.000027348204,0.00004053893,0.00022407284,0.00006195855],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014222445,0.0010489492,0.0085835755,0.0014318837,0.001989707,0.0001856683,0.0013670453,1.05810216e-7,0.00068332214,0.000013269674,0.74406666,0.23920755],"study_design_scores_gemma":[0.0034200372,0.0014967783,0.030818876,0.0013382274,0.00050598715,0.00009624809,0.00009384,0.000013559472,0.000587305,0.000020278652,0.9614854,0.00012350704],"about_ca_topic_score_codex":0.00003761143,"about_ca_topic_score_gemma":0.0000034478192,"teacher_disagreement_score":0.23908405,"about_ca_system_score_codex":0.000027187441,"about_ca_system_score_gemma":0.00017237412,"threshold_uncertainty_score":0.99858475},"labels":[],"label_agreement":null},{"id":"W2022186661","doi":"10.1586/17512433.2014.966812","title":"New treatments for the motor symptoms of Parkinson’s disease","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Levodopa; Medicine; Dyskinesia; Parkinson's disease; Dopaminergic; Clinical trial; Pharmacology; Dopamine; Disease; Internal medicine","score_opus":0.10460723580474432,"score_gpt":0.512091733561126,"score_spread":0.40748449775638174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022186661","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000036813274,0.9878746,0.00030189834,0.00064060505,0.003468806,0.0072104223,0.00033181606,0.000030168063,0.00013799297],"genre_scores_gemma":[0.000010039182,0.9881675,0.0011659464,0.0039194617,0.0030001972,0.0020920124,0.00028034468,0.000095854026,0.0012686318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943867,0.0007492876,0.0032357522,0.0008044332,0.00040505498,0.00041877778],"domain_scores_gemma":[0.992593,0.0031687852,0.0022214546,0.00093998096,0.00020018626,0.00087659905],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001014642,0.00068555126,0.0070618833,0.00010085218,0.00006123743,0.000004266812,0.000557495,0.00033399506,0.001295399],"category_scores_gemma":[0.0008839336,0.00036415533,0.0048540332,0.00020124731,0.00020243747,0.0000331104,0.00013426307,0.000330221,0.00007647314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036480633,0.00096022175,0.000035257486,0.07146603,0.0044016247,0.000023887571,0.00000308937,1.6780428e-8,4.9596406e-7,0.00004182085,0.076572746,0.84613],"study_design_scores_gemma":[0.0035166657,0.0012175313,0.00017606585,0.05284668,0.030744275,0.000010455371,6.2790326e-7,0.000011348472,0.0000028753464,0.000027505897,0.91122437,0.000221632],"about_ca_topic_score_codex":0.000015758424,"about_ca_topic_score_gemma":3.0984032e-7,"teacher_disagreement_score":0.84590834,"about_ca_system_score_codex":0.00009228951,"about_ca_system_score_gemma":0.00157375,"threshold_uncertainty_score":0.999881},"labels":[],"label_agreement":null},{"id":"W2022225262","doi":"10.1586/ecp.12.20","title":"Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis","year":2012,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Internal medicine; Esomeprazole; Community-acquired pneumonia; Lansoprazole; Proton-pump inhibitor; Pneumonia; Pantoprazole; Cohort study; MEDLINE; Odds ratio; Omeprazole; Incidence (geometry)","score_opus":0.3999750204036263,"score_gpt":0.5427896278345071,"score_spread":0.1428146074308808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022225262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020843085,0.99208766,0.000011632945,0.001741735,0.0005578643,0.00507912,0.000040917803,0.0000417226,0.00023091577],"genre_scores_gemma":[0.00033404148,0.9894188,0.000055306526,0.0062579545,0.00043259579,0.0031634658,0.00012556181,0.000062318024,0.00014998108],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9854675,0.008295867,0.0048450674,0.00037077576,0.00059251615,0.0004282508],"domain_scores_gemma":[0.9873603,0.0035823614,0.0071602566,0.00096358405,0.00061927363,0.00031423176],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0076146116,0.00068124826,0.014228393,0.0002981764,0.00024411366,0.000005186218,0.0006202153,0.0005928409,0.0010332422],"category_scores_gemma":[0.0010978525,0.0003145932,0.0067762164,0.0016862489,0.0007315204,0.00005588839,0.00026291749,0.0016326219,0.000030064453],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057130004,0.0054033175,0.00043965215,0.13195872,0.6122277,0.000022626475,0.00043286025,3.2389863e-7,0.000044047563,0.0000022308013,0.006836268,0.24257512],"study_design_scores_gemma":[0.00030852522,0.00020395301,0.0002176472,0.0067784875,0.33650282,0.000011543972,0.000020815316,1.9797992e-7,0.000024011302,2.0592805e-7,0.6557441,0.00018772986],"about_ca_topic_score_codex":0.0000072155262,"about_ca_topic_score_gemma":0.00002443741,"teacher_disagreement_score":0.6489078,"about_ca_system_score_codex":0.00011169534,"about_ca_system_score_gemma":0.0010103512,"threshold_uncertainty_score":0.9999306},"labels":[],"label_agreement":null},{"id":"W2057262282","doi":"10.1586/ecp.11.66","title":"Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response","year":2011,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Drug; Pharmacodynamics; Inflammation; Pharmacokinetics; Transporter; Pharmacology; Drug response; Drug development; Disease; Immunology; Bioinformatics; Biology; Internal medicine","score_opus":0.13661755918258842,"score_gpt":0.5009253919986094,"score_spread":0.36430783281602097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057262282","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008910717,0.9838891,0.0001666711,0.007361246,0.0017608751,0.006356711,0.000166357,0.000067200635,0.00014275096],"genre_scores_gemma":[0.00008168801,0.98990536,0.0005851206,0.0030962906,0.0011213898,0.0037866947,0.000423747,0.00010883309,0.0008908512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99402857,0.001361301,0.003097447,0.0008201974,0.00021013377,0.00048234276],"domain_scores_gemma":[0.993742,0.0034638876,0.0015544333,0.0006849853,0.000251433,0.00030326968],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003805827,0.0006090201,0.0056776833,0.00033842967,0.00005825798,0.0000035412734,0.0004847077,0.0005416959,0.00093356735],"category_scores_gemma":[0.00028303123,0.0004223905,0.0016697189,0.00046498232,0.00025318126,0.0000770602,0.00003187912,0.0008760141,0.00003075067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014048232,0.00077633554,0.000019551226,0.096541844,0.00038409285,0.000021504287,0.00024249256,1.1172485e-8,0.0005049805,0.000041247615,0.01235978,0.88770336],"study_design_scores_gemma":[0.0017369133,0.00017013335,0.00020723924,0.06581675,0.0017181798,0.0000106169555,0.000011614148,7.9641626e-7,0.0003101695,0.00003235507,0.92963916,0.00034607394],"about_ca_topic_score_codex":0.000008586275,"about_ca_topic_score_gemma":0.000035528716,"teacher_disagreement_score":0.91727936,"about_ca_system_score_codex":0.0000768352,"about_ca_system_score_gemma":0.0009873366,"threshold_uncertainty_score":0.99997973},"labels":[],"label_agreement":null},{"id":"W2070243746","doi":"10.1586/17512433.2013.811237","title":"Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease","year":2013,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Disease; Memantine; Clinical trial; Dementia; Intensive care medicine; Mechanism (biology); Drug development; Drug; Pharmacology; Internal medicine","score_opus":0.45305085717861787,"score_gpt":0.6046495154727972,"score_spread":0.15159865829417934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070243746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.1532975e-7,0.8874337,0.10110865,0.0020400619,0.0044909474,0.004762554,0.00011408068,0.000029266374,0.000020534739],"genre_scores_gemma":[8.145937e-7,0.9629966,0.029781247,0.0033790858,0.001451603,0.00226609,0.00004849793,0.00004223836,0.000033801516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936208,0.001610339,0.0031936262,0.00081189955,0.00040882544,0.00035450482],"domain_scores_gemma":[0.9795478,0.016452197,0.002171962,0.001140407,0.0003423165,0.00034529692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017439459,0.00055501214,0.0037395805,0.000090548514,0.00008709134,0.000022937566,0.0019659237,0.00014722928,0.00008842],"category_scores_gemma":[0.00043114836,0.00030946295,0.0033330012,0.00035025942,0.000353888,0.00014811006,0.00030768118,0.000237864,0.000020599324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020593427,0.0010752603,6.4078955e-7,0.017684184,0.0011874188,0.0000025196005,0.0000199418,0.000029474451,4.476137e-7,0.0010933598,0.0050510378,0.9738351],"study_design_scores_gemma":[0.0005999782,0.00022488624,0.000016572765,0.009971621,0.0040936493,0.000002460775,6.925624e-7,0.0086838845,0.0000020175119,0.00023130407,0.9758977,0.00027522433],"about_ca_topic_score_codex":0.0000062514346,"about_ca_topic_score_gemma":1.1150499e-7,"teacher_disagreement_score":0.9735599,"about_ca_system_score_codex":0.000062595536,"about_ca_system_score_gemma":0.0015436757,"threshold_uncertainty_score":0.99993575},"labels":[],"label_agreement":null},{"id":"W2072903209","doi":"10.1586/17512433.2014.913980","title":"Personalized pharmacotherapy in diabetes care using clinical pharmacology data of basal insulin analogues","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Kingston General Hospital","funders":"","keywords":"Medicine; Clinical pharmacology; Insulin; Basal insulin; Pharmacotherapy; Diabetes mellitus; Pharmacology; Basal (medicine); Clinical Practice; Drug; Personalized medicine; Type 2 diabetes; Bioinformatics; Internal medicine; Endocrinology; Biology","score_opus":0.37505185735522667,"score_gpt":0.6371617593276121,"score_spread":0.26210990197238543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072903209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003369927,0.9857228,0.000013683638,0.0007884037,0.0075350855,0.004738024,0.0002709052,0.000042455278,0.00055167935],"genre_scores_gemma":[0.000031793454,0.9773635,0.0013843781,0.011690891,0.0075820596,0.00021658381,0.0014540156,0.00015730059,0.00011945405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9787276,0.008662963,0.00888074,0.0018146939,0.0008641453,0.0010498822],"domain_scores_gemma":[0.98763406,0.0062453947,0.0034750248,0.0014554268,0.00059760245,0.0005924705],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01197535,0.0009595698,0.0149153285,0.00073530833,0.000054827873,0.0000100937,0.0025185747,0.0010406169,0.0042598806],"category_scores_gemma":[0.0019209585,0.0007127339,0.0028503903,0.0011588582,0.0019189818,0.0001641623,0.0014205073,0.0026924661,0.00015333453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000251733,0.0014424367,0.0011970435,0.19150521,0.002351177,0.00006130112,0.000021982125,2.4103494e-7,0.000029194593,0.0000031495697,0.13665344,0.6664831],"study_design_scores_gemma":[0.007133485,0.0009308898,0.000065397086,0.0636287,0.005292382,0.000003043178,0.000015727246,0.0005053982,0.000021265987,0.0000035379294,0.92189837,0.00050180167],"about_ca_topic_score_codex":0.000013839717,"about_ca_topic_score_gemma":0.0000020358304,"teacher_disagreement_score":0.78524494,"about_ca_system_score_codex":0.00012681607,"about_ca_system_score_gemma":0.0017855563,"threshold_uncertainty_score":0.9997093},"labels":[],"label_agreement":null},{"id":"W2074592693","doi":"10.1586/ecp.11.71","title":"Macrocyclic antibiotics: a novel class of drug for the treatment of<i>Clostridium difficile</i>infection","year":2011,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital; Saskatchewan Health Authority","funders":"","keywords":"Medicine; Clostridium difficile; Antibiotics; Antimicrobial; Drug; Microbiology; Intensive care medicine; Pharmacology; Biology","score_opus":0.08400978777234012,"score_gpt":0.475008023608945,"score_spread":0.39099823583660487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074592693","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010615937,0.26121604,0.00013115258,0.0023313533,0.716216,0.0073873242,0.001347453,0.000050718645,0.00070401654],"genre_scores_gemma":[0.0024287172,0.67339814,0.00022271484,0.0002849685,0.32252106,0.00011909884,0.00031944108,0.00008156272,0.0006242804],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99284303,0.0004525243,0.004188048,0.0008682923,0.0010218723,0.0006262542],"domain_scores_gemma":[0.98138016,0.013076659,0.002442701,0.0010472961,0.0017516714,0.00030150783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019520211,0.0006704823,0.0045890287,0.00019778904,0.00008436271,0.000005248521,0.00057683024,0.0010518035,0.0006865636],"category_scores_gemma":[0.004011726,0.00042415218,0.0028731867,0.0004083465,0.0009937424,0.0000349961,0.00015536055,0.0010400747,0.00001900872],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029688955,0.0074458243,0.000037161375,0.015836777,0.0020304653,0.000009201616,0.00009273148,7.2840993e-7,0.018695299,0.000011329331,0.93091077,0.021960814],"study_design_scores_gemma":[0.0062055173,0.004525394,0.000022041437,0.0038201646,0.002635957,0.000005925666,0.000014737249,0.00004765794,0.19760273,0.0000026375703,0.7848806,0.00023665828],"about_ca_topic_score_codex":0.0005185089,"about_ca_topic_score_gemma":0.00001846218,"teacher_disagreement_score":0.4121821,"about_ca_system_score_codex":0.00021109506,"about_ca_system_score_gemma":0.0016717421,"threshold_uncertainty_score":0.999821},"labels":[],"label_agreement":null},{"id":"W2079915635","doi":"10.1586/ecp.10.22","title":"Welcome to ‘Clinical Pharmacology of Ion Channels’","year":2010,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Ion channel regulation and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Clinical pharmacology; Ion channel; Pharmacology; Neuroscience; Internal medicine; Receptor","score_opus":0.06321268307145342,"score_gpt":0.4798959462211461,"score_spread":0.41668326314969273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079915635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6318278,0.013231149,0.0013568558,0.017094241,0.33256865,0.001840997,0.00003480093,0.00004476394,0.002000785],"genre_scores_gemma":[0.7324321,0.09627628,0.002187232,0.052073646,0.11529129,0.00019593326,0.0002010298,0.00006591535,0.0012765382],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963895,0.00064260286,0.0019775755,0.00053197355,0.00018611367,0.00027222352],"domain_scores_gemma":[0.9979821,0.00032748465,0.00062209973,0.00034126814,0.00042256853,0.00030449135],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023453198,0.00020774109,0.0009593703,0.000073863885,0.000038724174,0.0000024491521,0.00039211792,0.00044126404,0.0018725091],"category_scores_gemma":[0.0012757877,0.00017877758,0.0005617773,0.00018357621,0.00034478572,0.000006461722,0.00021650654,0.00042518362,0.000068681],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053600885,0.0006491614,0.0011746925,0.0003744553,0.00016653544,0.0000025181719,0.000015636788,0.000012941389,0.3641838,0.000047468886,0.6141246,0.018712157],"study_design_scores_gemma":[0.0014397429,0.0010056067,0.0016086121,0.00009696415,0.000047667803,0.000009701968,0.0000064617548,0.000097423865,0.13038394,0.000011810242,0.8651244,0.00016769017],"about_ca_topic_score_codex":0.000005283372,"about_ca_topic_score_gemma":0.0000016681004,"teacher_disagreement_score":0.25099975,"about_ca_system_score_codex":0.0000049156633,"about_ca_system_score_gemma":0.00015185698,"threshold_uncertainty_score":0.9990399},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2086704957","doi":"10.1586/17512433.2015.1018182","title":"Pharmacological strategies for prevention of postoperative atrial fibrillation","year":2015,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Aurora Foundation; Aurora Research Institute","keywords":"Medicine; Atrial fibrillation; Pathophysiology; Myocardial infarction; Cardiology; Heart failure; Cardiac surgery; Internal medicine; Incidence (geometry); Stroke (engine); Intensive care medicine","score_opus":0.4085152116518038,"score_gpt":0.6236671534498444,"score_spread":0.21515194179804054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086704957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009759863,0.9855285,0.00028178305,0.0013059776,0.0044810376,0.007477995,0.000049188213,0.000037781938,0.0008279393],"genre_scores_gemma":[0.000007554104,0.9854475,0.0021186494,0.00072980585,0.010558461,0.000048705897,0.00050733186,0.000040234052,0.00054171105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931424,0.0013633608,0.004336552,0.00052445213,0.00038450904,0.0002487123],"domain_scores_gemma":[0.99376184,0.0022765077,0.002790351,0.00024032654,0.0007446642,0.00018628546],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028027226,0.00043294198,0.006782173,0.0001599203,0.000034781875,0.0000063682346,0.00022350569,0.0005274062,0.0010830293],"category_scores_gemma":[0.0013218103,0.0002947062,0.004323977,0.00032838542,0.0002473761,0.0001355134,0.00012975342,0.00033343362,0.000026338188],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059947313,0.000034680204,0.000013810096,0.059873868,0.001561982,0.0000030963126,0.000014380948,0.000002336729,0.0000070180195,0.00032443632,0.08682916,0.8507358],"study_design_scores_gemma":[0.0030995102,0.0017142742,0.000005731103,0.019253707,0.0077824807,0.000008715149,0.000013793564,0.000028987533,0.000006769005,0.00010728008,0.96775603,0.00022270047],"about_ca_topic_score_codex":0.0000020554785,"about_ca_topic_score_gemma":1.9645647e-7,"teacher_disagreement_score":0.8809269,"about_ca_system_score_codex":0.00007071756,"about_ca_system_score_gemma":0.0013178267,"threshold_uncertainty_score":0.9999505},"labels":[],"label_agreement":null},{"id":"W2093908956","doi":"10.1586/ecp.13.15","title":"The potential and promise of mefenamic acid","year":2013,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Mefenamic acid; Medicine; Pharmacology; Drug","score_opus":0.0682458797305156,"score_gpt":0.5103905814010125,"score_spread":0.44214470167049685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093908956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007583997,0.99115723,0.0000033324347,0.0004913226,0.0040977467,0.0038886664,0.000008450212,0.0000161048,0.00026129404],"genre_scores_gemma":[0.000008889288,0.99523866,0.00017286978,0.0013020902,0.0025143542,0.0004838418,0.000024420076,0.00004626981,0.00020862493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99416494,0.001531922,0.0032706545,0.00041728484,0.00030063585,0.00031457734],"domain_scores_gemma":[0.9953391,0.0017829549,0.0018711586,0.0004839384,0.00023462469,0.00028823756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002932011,0.00040207422,0.0055504683,0.000063950014,0.000053474858,0.000003825688,0.00033255,0.00046350894,0.0005706821],"category_scores_gemma":[0.0013282305,0.00020186159,0.0013756353,0.00014629106,0.0007327985,0.000034808556,0.0001905801,0.00084060675,0.000070527865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004526924,0.00011105426,0.0000024067813,0.14869139,0.00043598795,0.00002566006,0.000005135135,1.6113113e-9,0.000036434478,0.000013302475,0.066738814,0.78389454],"study_design_scores_gemma":[0.0009192106,0.000426485,0.000009406986,0.055439807,0.0024070533,0.00009787897,0.000001990382,0.000006568499,0.000044849792,0.000005743655,0.9404887,0.00015231445],"about_ca_topic_score_codex":0.000003850616,"about_ca_topic_score_gemma":1.910364e-7,"teacher_disagreement_score":0.87374985,"about_ca_system_score_codex":0.000023242612,"about_ca_system_score_gemma":0.00064313586,"threshold_uncertainty_score":0.8231677},"labels":[],"label_agreement":null},{"id":"W2094669820","doi":"10.1586/ecp.10.123","title":"Follow-through after breakthrough","year":2010,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"","keywords":"Medicine; Intensive care medicine; Pharmacology","score_opus":0.0403159750612065,"score_gpt":0.4833199032850764,"score_spread":0.4430039282238699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094669820","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11710643,0.3503704,0.00034051543,0.45956194,0.031216912,0.0018878108,0.000010234086,0.00030688176,0.039198887],"genre_scores_gemma":[0.15578659,0.62044406,0.008439914,0.21132319,0.0028133926,0.0001226058,0.000013174024,0.000030325498,0.0010267267],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978488,0.00015021692,0.0012366311,0.0003569571,0.00014393227,0.00026348024],"domain_scores_gemma":[0.9986865,0.0003528889,0.00026318713,0.0004241837,0.00013659004,0.00013663151],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0007260289,0.0001750766,0.0011323801,0.000032828684,0.00003176266,0.0000011027089,0.00020188146,0.0027999931,0.009509529],"category_scores_gemma":[0.0005966973,0.00012143373,0.0005434752,0.00018729587,0.00072990736,0.000058524634,0.00010004506,0.004406715,0.00028402774],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010399325,0.0016696932,0.002852847,0.0028312409,0.00078380445,0.00039637508,0.00009801747,2.075617e-8,0.02213777,0.0016897592,0.8698276,0.09667292],"study_design_scores_gemma":[0.0020575854,0.00038619887,0.002216268,0.0009943836,0.00027969753,0.00016390313,0.0000042453776,0.0000040758723,0.00844361,0.0001380143,0.98518556,0.00012644524],"about_ca_topic_score_codex":0.000010177796,"about_ca_topic_score_gemma":0.0000021020621,"teacher_disagreement_score":0.27007368,"about_ca_system_score_codex":0.0000054664333,"about_ca_system_score_gemma":0.0001340169,"threshold_uncertainty_score":0.99849457},"labels":[],"label_agreement":null},{"id":"W2100338188","doi":"10.1586/17512433.2014.904744","title":"A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":259,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Acetaminophen; Medicine; Analgesic; acetaminophen overdose; Toxicity; Drug overdose; Opioid; Epidemiology; Anesthesia; Pharmacology; Intensive care medicine; Poison control; Acetylcysteine; Emergency medicine; Internal medicine","score_opus":0.4224043631539794,"score_gpt":0.6106134601020781,"score_spread":0.18820909694809868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100338188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012395512,0.9813245,0.00001820464,0.0092647085,0.0026995589,0.004018365,0.00009815787,0.00002620016,0.0013107732],"genre_scores_gemma":[0.00081642653,0.9451999,0.000045036373,0.051270775,0.0012762689,0.0012274304,0.00007057612,0.000040926552,0.00005263745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9522247,0.042005163,0.0040921047,0.00082381064,0.00024766847,0.00060655386],"domain_scores_gemma":[0.94502527,0.05097753,0.0028963804,0.0006316019,0.0002785397,0.00019066255],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.025031667,0.0007108069,0.005667443,0.00028771238,0.0001887079,0.0000038525027,0.0013150186,0.0015096922,0.00088803086],"category_scores_gemma":[0.0077488683,0.00037913426,0.0011889595,0.00085556245,0.001710359,0.000051054943,0.0002597389,0.004920923,0.000051862837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005273337,0.0022469417,0.0002846077,0.064265415,0.0019203668,0.000037450416,0.0017775629,0.00001942972,0.000018485938,0.009600172,0.07890978,0.8403925],"study_design_scores_gemma":[0.0008857169,0.0008718607,0.000059994232,0.01065686,0.0010013697,0.000040164043,0.00014134418,0.00010540956,0.000050249066,0.000808591,0.9850489,0.00032956232],"about_ca_topic_score_codex":0.0001555978,"about_ca_topic_score_gemma":0.000013343237,"teacher_disagreement_score":0.9061391,"about_ca_system_score_codex":0.00012850224,"about_ca_system_score_gemma":0.00029917102,"threshold_uncertainty_score":0.99986607},"labels":[],"label_agreement":null},{"id":"W2106544163","doi":"10.1586/ecp.09.5","title":"Cyclobenzaprine: a new look at an old pharmacological agent","year":2009,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Medicine; Tricyclic; Anticholinergic; Fibromyalgia; Intensive care medicine; Drug; Pharmacology; Psychiatry","score_opus":0.11779674360950539,"score_gpt":0.5229288800432607,"score_spread":0.4051321364337553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106544163","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52070224,0.37472,0.00014615666,0.08432865,0.0045755347,0.0043507647,0.000012494416,0.00032017086,0.010843983],"genre_scores_gemma":[0.21765827,0.6964993,0.0059877527,0.06550582,0.0046754493,0.0001241037,0.00013975734,0.00007658288,0.009332975],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99539554,0.00075853436,0.0018670155,0.0007158113,0.00061195693,0.0006511315],"domain_scores_gemma":[0.9972754,0.00046553873,0.00035577881,0.0004918503,0.00018994877,0.0012215009],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015788121,0.0003201208,0.0017552079,0.000081977894,0.00006744689,0.0000050619874,0.00046581804,0.00029110903,0.025516728],"category_scores_gemma":[0.00053637393,0.00023400645,0.00071280595,0.0002998639,0.00031496448,0.00009751319,0.00018011786,0.00079406716,0.00045797482],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012145385,0.0027268163,0.00077474717,0.0042085866,0.00033966015,0.00051046815,0.00004874584,9.708756e-7,0.046776637,0.00021359662,0.8566751,0.086510144],"study_design_scores_gemma":[0.017423982,0.014549488,0.027535105,0.006778092,0.0009419241,0.0007239751,0.000021025411,0.0004326751,0.0227802,0.00022210073,0.907845,0.0007463967],"about_ca_topic_score_codex":0.000016813681,"about_ca_topic_score_gemma":2.8491868e-7,"teacher_disagreement_score":0.32177928,"about_ca_system_score_codex":0.00016040141,"about_ca_system_score_gemma":0.0006671061,"threshold_uncertainty_score":0.9753741},"labels":[],"label_agreement":null},{"id":"W2115180385","doi":"10.1586/17512433.2.2.181","title":"Lipid-based delivery of CpG oligodeoxynucleotides for cancer immunotherapy","year":2009,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"CpG Oligodeoxynucleotide; Medicine; Biodistribution; Immunotherapy; Immune system; Cancer; Cancer research; Pharmacology; Cancer immunotherapy; Clinical trial; Monoclonal antibody; Immunology; Antibody; In vitro; Biology; Internal medicine; Biochemistry; DNA methylation","score_opus":0.04964886940516828,"score_gpt":0.46639185258536986,"score_spread":0.4167429831802016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115180385","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6270218,0.36132434,0.0018220065,0.0053186165,0.002943854,0.0011100854,0.00007197714,0.00002389401,0.00036342265],"genre_scores_gemma":[0.45951518,0.4870182,0.0018509389,0.04960504,0.0016969302,0.00015020519,0.000043611653,0.00002467065,0.00009522791],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817026,0.00018204436,0.0010491018,0.00030933565,0.00009156355,0.00019768917],"domain_scores_gemma":[0.99874645,0.00014568344,0.00043879944,0.0002679687,0.00033236467,0.00006870231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056536996,0.00016001593,0.00070151244,0.000029660785,0.0000196245,0.0000019293518,0.0003424112,0.00016246151,0.00026467396],"category_scores_gemma":[0.00014756026,0.00013282958,0.0005740801,0.00006248138,0.00015331715,0.000004272516,0.000028365368,0.000092547816,0.0000025594193],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086200907,0.00039771598,0.00035016288,0.00046358223,0.00017960604,7.317914e-7,0.000007828893,0.000017654178,0.6832922,0.000015804922,0.17929958,0.13511309],"study_design_scores_gemma":[0.0015018187,0.001907651,0.0008597159,0.0006124893,0.000057735037,9.263886e-7,0.0000036001384,0.00008638408,0.48642632,0.000024774106,0.5083583,0.00016029066],"about_ca_topic_score_codex":0.000019788604,"about_ca_topic_score_gemma":0.0000034529185,"teacher_disagreement_score":0.32905874,"about_ca_system_score_codex":0.0000061277315,"about_ca_system_score_gemma":0.00020901675,"threshold_uncertainty_score":0.5416633},"labels":[],"label_agreement":null},{"id":"W2124551261","doi":"10.1586/ecp.10.16","title":"Strategies for the real-time detection of Ca<sup>2+</sup>channel events of single cells: recent advances and new possibilities","year":2010,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine","score_opus":0.09645986708757702,"score_gpt":0.4348078142889891,"score_spread":0.3383479472014121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124551261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95520926,0.033813614,0.00059405883,0.0022047746,0.0060107214,0.001786057,0.000036984347,0.00004953807,0.00029500257],"genre_scores_gemma":[0.54355115,0.45376724,0.00026716877,0.0017426248,0.00047178983,0.000050207283,5.4195226e-7,0.000017184011,0.00013207772],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822617,0.0001850316,0.00090641994,0.0003217068,0.00016922914,0.00019146608],"domain_scores_gemma":[0.99669135,0.0025527917,0.0003958214,0.00019566227,0.00007863018,0.00008573856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006576235,0.00013251911,0.0005397933,0.00003583264,0.000053242726,0.000004841665,0.00031311146,0.000064766915,0.0000836764],"category_scores_gemma":[0.0012675496,0.00008728888,0.00015864187,0.00017020134,0.00042211128,0.000231254,0.00007352723,0.00019187882,0.0000015857776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008297193,0.0001089052,0.0000018916531,0.00074046105,0.0000044452545,5.1824026e-7,0.00011286574,0.00011615864,0.9724813,0.000023905559,0.00070913765,0.025617428],"study_design_scores_gemma":[0.00048406507,0.00073254626,0.000015564805,0.00022575908,0.00003448588,0.000005748579,0.000079951904,0.004562192,0.9467191,0.00034553953,0.046699904,0.00009511884],"about_ca_topic_score_codex":0.000017373493,"about_ca_topic_score_gemma":0.0000017614087,"teacher_disagreement_score":0.41995364,"about_ca_system_score_codex":0.0000046949217,"about_ca_system_score_gemma":0.0000905061,"threshold_uncertainty_score":0.35595372},"labels":[],"label_agreement":null},{"id":"W2125393397","doi":"10.1586/17512433.2.1.87","title":"Iatrogenic glaucoma therapy failure: the adverse effects of topical antiglaucoma medication treatment outcome","year":2008,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Glaucoma; Trabeculectomy; Adverse effect; Optic nerve; Optic neuropathy; Brimonidine; Medical therapy; Pharmacotherapy; Intensive care medicine; Ophthalmology; Dermatology; Surgery; Internal medicine","score_opus":0.05212792360520359,"score_gpt":0.44261011502780534,"score_spread":0.39048219142260177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125393397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84667164,0.13404068,0.000034283268,0.016116496,0.00138044,0.0014673269,0.0000013747814,0.000025514959,0.00026223197],"genre_scores_gemma":[0.61466974,0.3746503,0.00037036784,0.009463243,0.00060453004,0.00011109102,0.000012095115,0.000015293266,0.00010331389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676704,0.00072306895,0.0016239533,0.00030566246,0.00033540383,0.00024487457],"domain_scores_gemma":[0.9974779,0.0012346521,0.00054634426,0.00042663628,0.00012694183,0.0001875293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005238261,0.00022766656,0.0013804078,0.000043244556,0.00006654525,5.8455856e-7,0.00026187234,0.00017456594,0.00049905945],"category_scores_gemma":[0.00050134014,0.00011841058,0.0012454067,0.00018454768,0.0007382482,0.000030894233,0.000045686596,0.00027315243,0.000034136014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076731434,0.0029570358,0.9011947,0.0021847484,0.0010778313,0.00015961318,0.00031825903,1.5839289e-8,0.008561137,0.00011915869,0.05017192,0.032488268],"study_design_scores_gemma":[0.006756793,0.0029838786,0.79214364,0.0006439927,0.0004992818,0.00020360292,0.000030006606,0.000015615422,0.007508042,0.00001616928,0.18906562,0.00013335461],"about_ca_topic_score_codex":0.000043244374,"about_ca_topic_score_gemma":0.000002440683,"teacher_disagreement_score":0.24060962,"about_ca_system_score_codex":0.0000319409,"about_ca_system_score_gemma":0.00020337783,"threshold_uncertainty_score":0.5464351},"labels":[],"label_agreement":null},{"id":"W2125917241","doi":"10.1586/17512433.2014.928196","title":"Sofosbuvir (Sovaldi) for the treatment of hepatitis C","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sofosbuvir; Medicine; Simeprevir; Ribavirin; Hepatitis C; Pegylated interferon; Daclatasvir; Hepatitis C virus; Clinical trial; Pharmacology; Internal medicine; Intensive care medicine; Virology; Virus","score_opus":0.29471990705978673,"score_gpt":0.6339532387622916,"score_spread":0.33923333170250486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125917241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014058455,0.9855241,0.00015033732,0.0018685311,0.0029965686,0.00836656,0.00013923648,0.00002275482,0.0009304793],"genre_scores_gemma":[0.0000014594355,0.9871946,0.0008955181,0.003371509,0.004536685,0.0030775007,0.0001492203,0.0000946419,0.00067889475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99178433,0.0018842276,0.004694456,0.00064924196,0.00049938733,0.00048836385],"domain_scores_gemma":[0.98252046,0.013820847,0.0017978704,0.0010211137,0.0005217067,0.00031800717],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030765997,0.00053524657,0.009748601,0.00012546538,0.000058561116,0.0000036220258,0.0006214941,0.00052516564,0.0025439989],"category_scores_gemma":[0.0028287678,0.00027952672,0.004529945,0.00032044965,0.00071511924,0.00002475652,0.00009952191,0.00052095484,0.00014198711],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060642,0.0007279276,0.000021239468,0.11941946,0.001355432,0.000011223304,0.00001049404,1.3364953e-8,7.620733e-7,0.000021488533,0.13973786,0.73863345],"study_design_scores_gemma":[0.0016762199,0.0036225105,0.000009651449,0.04656751,0.0041575977,0.000015973385,7.3600665e-7,0.000023922024,0.000014913444,0.0000048900138,0.9437206,0.00018552142],"about_ca_topic_score_codex":0.000093779374,"about_ca_topic_score_gemma":0.000007501621,"teacher_disagreement_score":0.8039827,"about_ca_system_score_codex":0.00014389068,"about_ca_system_score_gemma":0.0013265578,"threshold_uncertainty_score":0.99996567},"labels":[],"label_agreement":null},{"id":"W2138802019","doi":"10.1586/ecp.10.133","title":"Hydrogen sulfide and the metabolic syndrome","year":2010,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Sulfur Compounds in Biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Hyperinsulinemia; Medicine; Hyperlipidemia; Metabolic syndrome; Internal medicine; Diabetes mellitus; Endocrinology; Vasodilation; Type 2 diabetes; Hydrogen sulfide; Blood pressure; Insulin resistance; Pharmacology; Chemistry","score_opus":0.06145998671178908,"score_gpt":0.4713678816675021,"score_spread":0.409907894955713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138802019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011598098,0.9923388,0.000008292283,0.00065577426,0.0045413994,0.0017180532,0.000034189143,0.000014268368,0.0005732757],"genre_scores_gemma":[0.000013382846,0.9869971,0.00040394475,0.008478626,0.0031069464,0.00053709076,0.0001771067,0.00007026831,0.00021551929],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99217975,0.0034518752,0.002849013,0.00092843117,0.00017341925,0.00041750105],"domain_scores_gemma":[0.9954191,0.0016539868,0.0015416833,0.0010405114,0.00014236158,0.00020236587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041124886,0.00059878005,0.005490903,0.000062572006,0.00007455108,0.000007425785,0.0013117697,0.0011721761,0.0002876767],"category_scores_gemma":[0.0021564164,0.00034260517,0.0018429407,0.00018024191,0.0021535733,0.0000031502052,0.00089586584,0.0011909383,0.000055004122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007055548,0.000115066665,0.0000054434126,0.009578386,0.0011094168,0.00001859081,0.000003911992,1.2772614e-8,0.00011152628,0.00021929188,0.03047942,0.9582884],"study_design_scores_gemma":[0.0011195246,0.00017271911,0.0000029477123,0.003938896,0.0013598684,0.00078433467,8.9380393e-7,5.8668894e-7,0.00007262658,0.00003953705,0.99217397,0.00033409335],"about_ca_topic_score_codex":0.0000074403415,"about_ca_topic_score_gemma":0.0000018756897,"teacher_disagreement_score":0.96169454,"about_ca_system_score_codex":0.00000598548,"about_ca_system_score_gemma":0.00044121442,"threshold_uncertainty_score":0.9999026},"labels":[],"label_agreement":null},{"id":"W2143171616","doi":"10.1586/17512433.1.1.73","title":"Integrating pharmacogenomics into oncology clinical practice","year":2008,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"U.S. Food and Drug Administration; Genome Canada","keywords":"Pharmacogenomics; Medicine; Irinotecan; Oncology; Genotyping; Internal medicine; Trastuzumab; Tamoxifen; Clinical trial; Clinical Oncology; Clinical Practice; Bioinformatics; Cancer; Colorectal cancer; Medical physics; Pharmacology; Genotype; Breast cancer; Family medicine; Genetics","score_opus":0.10807660934412486,"score_gpt":0.5524788650701478,"score_spread":0.4444022557260229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143171616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13045631,0.7599785,0.014310323,0.02538731,0.039879613,0.0029411633,0.000041755207,0.00009922965,0.02690581],"genre_scores_gemma":[0.032777656,0.8210689,0.029137066,0.11026196,0.0063512726,0.00008950237,0.000054344084,0.000043896598,0.00021540505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950193,0.0014212682,0.0023838165,0.00064357684,0.00019904996,0.00033297652],"domain_scores_gemma":[0.99709177,0.00069572777,0.0010308385,0.00041111006,0.00047388166,0.00029664798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036080386,0.0002607029,0.001111947,0.00003424022,0.0001031206,0.0000031294876,0.00052247406,0.00040705953,0.0003777106],"category_scores_gemma":[0.0017682493,0.00022740677,0.00067910645,0.00012569592,0.0005145198,0.000010303955,0.00029393932,0.000600125,0.000044291697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011986513,0.0016516055,0.0002649365,0.00043614605,0.0008535096,0.000092512455,0.00013515595,0.00000203831,0.24204628,0.00023864656,0.29762283,0.45545766],"study_design_scores_gemma":[0.0019222008,0.0017455849,0.000039933577,0.000150441,0.00015290482,0.00015507785,0.00004056099,0.0000415482,0.033127163,0.000037061865,0.9623568,0.00023071152],"about_ca_topic_score_codex":0.00002509195,"about_ca_topic_score_gemma":0.0000043825034,"teacher_disagreement_score":0.66473395,"about_ca_system_score_codex":0.000033244803,"about_ca_system_score_gemma":0.0008604224,"threshold_uncertainty_score":0.9273379},"labels":[],"label_agreement":null},{"id":"W2149842284","doi":"10.1586/ecp.10.130","title":"Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential","year":2010,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Sulfur Compounds in Biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pathogenesis; Hyperhomocysteinemia; Nitric oxide; Cystathionine beta synthase; Cystathionine gamma-lyase; Foam cell; Inflammation; Pharmacology; Bioinformatics; Homocysteine; Immunology; Cholesterol; Internal medicine; Biochemistry; Biology; Lipoprotein; Cysteine","score_opus":0.09260357773046925,"score_gpt":0.4664020495922916,"score_spread":0.37379847186182236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149842284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035972584,0.993258,0.0000068379927,0.00021407522,0.0015224695,0.001272324,0.00005138599,0.000004680989,0.000072972405],"genre_scores_gemma":[0.0012201051,0.9936421,0.00012661843,0.003242478,0.0013151611,0.00028437516,0.000103137674,0.00004770446,0.000018345592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99326026,0.0030690026,0.002470724,0.00069728284,0.00017908063,0.00032365468],"domain_scores_gemma":[0.9970433,0.00080344087,0.0012952699,0.00064321974,0.00012854957,0.00008623679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028805286,0.0004442258,0.0029319664,0.00007253066,0.00003350947,0.0000036538083,0.0011212688,0.0010022845,0.000115840565],"category_scores_gemma":[0.00058139046,0.00028066794,0.0010887717,0.00020384176,0.0005004061,0.0000031549846,0.00036541052,0.0006560513,0.000008111395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049147653,0.0003863027,0.00007126199,0.015694408,0.0004729361,0.0000062879944,0.000021092768,1.1165133e-7,0.029733602,0.000034794914,0.00248078,0.95104927],"study_design_scores_gemma":[0.00046024602,0.00036071512,0.000071128525,0.0038122528,0.0005985159,0.000072198454,0.0000041657454,0.0000017688252,0.00074078963,0.000011879261,0.9936115,0.0002548243],"about_ca_topic_score_codex":0.000004741159,"about_ca_topic_score_gemma":0.0000029794378,"teacher_disagreement_score":0.9911307,"about_ca_system_score_codex":0.000007601024,"about_ca_system_score_gemma":0.00028570922,"threshold_uncertainty_score":0.99996454},"labels":[],"label_agreement":null},{"id":"W2150595547","doi":"10.1586/17512433.2014.910111","title":"Understanding and preventing drug–drug and drug–gene interactions","year":2014,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal; Institut Universitaire de Gériatrie de Montréal","funders":"","keywords":"Drug; Medicine; Pharmacology; Pharmacogenetics; Drug interaction; Drug action; Cytochrome P450; Drug metabolism; Pharmacogenomics; Computational biology; Gene; Biology; Genetics; Internal medicine; Genotype","score_opus":0.4669670775692211,"score_gpt":0.6204686295753388,"score_spread":0.15350155200611765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150595547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012990407,0.9797756,0.00009377792,0.001608237,0.013673254,0.0022385584,0.00013202066,0.000081430175,0.002267198],"genre_scores_gemma":[0.00022985587,0.98257464,0.00058645714,0.009962912,0.0048487103,0.00037900746,0.00010228848,0.0001339429,0.0011821768],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9849058,0.0078329705,0.0046946304,0.0013574746,0.0003333765,0.0008757959],"domain_scores_gemma":[0.98722404,0.008291713,0.00286855,0.00047470912,0.00019648908,0.0009445205],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008425067,0.001062508,0.0064556105,0.00034917446,0.00037115696,0.000030285097,0.0008007892,0.0005766555,0.0022674657],"category_scores_gemma":[0.00063881517,0.0008993753,0.0013905343,0.00043597718,0.0010898615,0.00016061461,0.00088044966,0.0033220777,0.00008845997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005638725,0.00042211724,0.00003923445,0.057798743,0.0014849623,0.00003251235,0.00015247469,8.4459396e-7,0.000060365073,0.00024194182,0.19513544,0.74457496],"study_design_scores_gemma":[0.0015851593,0.000043467302,0.0000042070556,0.016150787,0.0054770093,0.00013987951,0.00002727193,0.00011367076,0.00014011965,0.0001580228,0.97540617,0.00075421063],"about_ca_topic_score_codex":0.000014025818,"about_ca_topic_score_gemma":0.0000058292103,"teacher_disagreement_score":0.78027076,"about_ca_system_score_codex":0.000100968995,"about_ca_system_score_gemma":0.0004205608,"threshold_uncertainty_score":0.99934566},"labels":[],"label_agreement":null},{"id":"W2155237015","doi":"10.1586/17512433.1.5.627","title":"Inflammatory reactions and drug response: importance of cytochrome P450 and membrane transporters","year":2008,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Drug; Pharmacology; Transporter; Cytochrome P450; ATP-binding cassette transporter; Biochemistry; Metabolism; Internal medicine; Chemistry","score_opus":0.041304335126176935,"score_gpt":0.4125003637328539,"score_spread":0.371196028606677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155237015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9038363,0.089308485,0.000034628007,0.0053869607,0.0004059838,0.0006653572,0.000011712802,0.000028891862,0.00032166461],"genre_scores_gemma":[0.5421715,0.4522797,0.0010790875,0.00372005,0.00022716614,0.00003726055,0.0000107348715,0.000019077796,0.0004554725],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99734,0.00024477806,0.0016834519,0.0003290708,0.0002165357,0.00018615474],"domain_scores_gemma":[0.9984006,0.000541248,0.0004588678,0.00023157918,0.0001204813,0.0002471775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015512756,0.00017460813,0.0013052551,0.00007272396,0.000049613507,6.1137604e-7,0.00008812866,0.00012506155,0.00042484835],"category_scores_gemma":[0.00015796983,0.00013599901,0.00024897707,0.00013493763,0.00077494467,0.000068090136,0.000013839776,0.0003019111,0.000002105269],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011227085,0.0014075324,0.044686165,0.02718165,0.0008677367,0.0014249916,0.0013381203,6.419396e-7,0.8747643,0.00025232742,0.028002849,0.008846562],"study_design_scores_gemma":[0.00886907,0.00092377,0.51142335,0.007087534,0.000809021,0.0005736723,0.00013304956,0.000018221235,0.03868758,0.000044428154,0.43100113,0.0004291969],"about_ca_topic_score_codex":0.0000055694654,"about_ca_topic_score_gemma":0.0000037780158,"teacher_disagreement_score":0.83607674,"about_ca_system_score_codex":0.000010858319,"about_ca_system_score_gemma":0.00021492367,"threshold_uncertainty_score":0.5545879},"labels":[],"label_agreement":null},{"id":"W2159243900","doi":"10.1586/ecp.12.53","title":"Clinical trials involving the oncolytic virus, reovirus: ready for prime time?","year":2012,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Oncolytic virus; Medicine; Carboplatin; Clinical trial; Internal medicine; Oncology; Chemotherapy; Paclitaxel; Cancer; Virus; Virology; Cisplatin","score_opus":0.28820894615084236,"score_gpt":0.6059017138304686,"score_spread":0.3176927676796263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159243900","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11767063,0.85252637,0.000509695,0.010160282,0.010266223,0.007327063,0.00014742123,0.000053713706,0.0013386137],"genre_scores_gemma":[0.036176678,0.8508912,0.002128637,0.07398162,0.033563912,0.0011338645,0.0002725148,0.0001354108,0.001716177],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9863972,0.008414427,0.003637644,0.0005753748,0.0003122134,0.00066311046],"domain_scores_gemma":[0.991432,0.005727071,0.0012297945,0.0008660371,0.00035560684,0.00038949886],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.045935422,0.00029733276,0.0018251017,0.000038409424,0.00012102424,0.000009671887,0.0009071326,0.0004470797,0.0010026041],"category_scores_gemma":[0.015478485,0.00019219905,0.0012496609,0.00014809788,0.0006008382,0.000012697153,0.0003098574,0.0005199428,0.00019535489],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003908762,0.00086567574,0.0004583336,0.00036110438,0.0006107109,0.0000010233834,0.00002087672,5.1290766e-7,0.29005978,0.000019220568,0.6039514,0.09974262],"study_design_scores_gemma":[0.0022923085,0.003335328,0.0001741586,0.0002551861,0.00020273768,0.000005046854,0.000007328625,0.000050403556,0.1039397,0.000021927053,0.88948613,0.00022974442],"about_ca_topic_score_codex":0.000008313436,"about_ca_topic_score_gemma":0.000005713096,"teacher_disagreement_score":0.28553477,"about_ca_system_score_codex":0.000024484585,"about_ca_system_score_gemma":0.00053441257,"threshold_uncertainty_score":0.9999106},"labels":[],"label_agreement":null},{"id":"W2171856054","doi":"10.1586/17512433.1.5.605","title":"Major malformations after first trimester exposure to aspirin and NSAIDs","year":2008,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Aspirin; Pharmacology; First trimester; Pregnancy; Internal medicine; Fetus","score_opus":0.0750737188366503,"score_gpt":0.47815359618923364,"score_spread":0.4030798773525833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171856054","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4059189,0.467671,0.0006857017,0.11211278,0.00314829,0.0030923174,0.000028748744,0.00009712864,0.007245122],"genre_scores_gemma":[0.49538526,0.33147013,0.0032976987,0.16662277,0.0011789616,0.00041162167,0.000019231262,0.000019463643,0.0015948606],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980735,0.00017389559,0.001154722,0.0002238001,0.0001767893,0.00019727205],"domain_scores_gemma":[0.99860686,0.0003835911,0.00018884802,0.00025771745,0.00011923093,0.00044377474],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006791791,0.00013336116,0.00078839617,0.000070947666,0.000047332658,0.0000013475835,0.00010148832,0.00011696087,0.0017506707],"category_scores_gemma":[0.00084277254,0.00009693211,0.0002092886,0.00016018758,0.00021180992,0.00009464036,0.000064654276,0.00024068763,0.00014371437],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000764372,0.0008819513,0.031357992,0.0048326715,0.00019678003,0.00011972279,0.00075014704,1.8679515e-7,0.00042048228,0.000020143916,0.89352745,0.06712811],"study_design_scores_gemma":[0.0029044915,0.0009755484,0.13976072,0.0042203157,0.00016244376,0.00022578458,0.000008456659,0.0000043791974,0.00048316576,0.000006274497,0.8511282,0.00012022348],"about_ca_topic_score_codex":0.0000032897924,"about_ca_topic_score_gemma":7.4335327e-7,"teacher_disagreement_score":0.13620088,"about_ca_system_score_codex":0.000013904344,"about_ca_system_score_gemma":0.00018945153,"threshold_uncertainty_score":0.99916184},"labels":[],"label_agreement":null},{"id":"W2195254757","doi":"10.1586/17512433.2016.1129896","title":"Transitional Pain Medicine: novel pharmacological treatments for the management of moderate to severe postsurgical pain","year":2015,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Pain management; Pain medicine; Anesthesia; Anesthesiology","score_opus":0.10306639285082494,"score_gpt":0.49263446091417434,"score_spread":0.3895680680633494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2195254757","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000092429196,0.20206478,0.033972558,0.18871547,0.54602695,0.026178597,0.00034051857,0.0001531342,0.0024555246],"genre_scores_gemma":[0.00014011134,0.36335605,0.0073087583,0.13083361,0.49124694,0.0028984258,0.0012591492,0.00011015675,0.0028467912],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918932,0.0023324902,0.0030068744,0.0008707474,0.0013841637,0.000512546],"domain_scores_gemma":[0.98231274,0.014743971,0.0009519762,0.00047323617,0.0009951779,0.0005229225],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.020464653,0.00061608246,0.0033165994,0.00010537634,0.00008314472,0.0000042627403,0.00067732617,0.0006791995,0.0016611217],"category_scores_gemma":[0.0015245164,0.0003558248,0.0011149847,0.00027961086,0.0005033742,0.000032546763,0.00011149101,0.0007789098,0.000018512188],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053746896,0.0016776689,0.000010308089,0.009457848,0.0051962943,0.000105887004,0.0000606255,0.000018878378,0.000032491633,0.00007417775,0.94532067,0.032670483],"study_design_scores_gemma":[0.0102228,0.0036280337,0.000052655334,0.007449888,0.0083714435,0.000007992047,0.00005636454,0.00070313003,0.000008295282,0.000045852,0.96915287,0.00030070095],"about_ca_topic_score_codex":0.000014875821,"about_ca_topic_score_gemma":4.9289855e-7,"teacher_disagreement_score":0.16129127,"about_ca_system_score_codex":0.0001358987,"about_ca_system_score_gemma":0.00043128434,"threshold_uncertainty_score":0.9998894},"labels":[],"label_agreement":null},{"id":"W2201080195","doi":"10.1586/17512433.2016.1112265","title":"Pharmacological approaches to CNS vasculitis: where are we at now?","year":2015,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Vasculitis; Azathioprine; Methotrexate; Intensive care medicine; Cyclophosphamide; Refractory (planetary science); Disease; Immunology; Internal medicine; Chemotherapy","score_opus":0.4049237408769511,"score_gpt":0.5265497279657719,"score_spread":0.12162598708882083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201080195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000020567845,0.9583309,0.000016901098,0.024559906,0.0056750844,0.005495695,0.00020645424,0.00014157312,0.005571416],"genre_scores_gemma":[8.548634e-7,0.9760798,0.00087626395,0.011161029,0.006054954,0.0018382063,0.000414992,0.00013238376,0.003441483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9894046,0.0025348538,0.00496662,0.0014999404,0.00076627743,0.0008276611],"domain_scores_gemma":[0.99391794,0.0012298241,0.0018484107,0.0008636522,0.00041195276,0.0017282113],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0027482163,0.0010127757,0.011411868,0.00023395296,0.00012306504,0.0000101269225,0.0008283605,0.0015819159,0.011581009],"category_scores_gemma":[0.0004917401,0.00066293,0.0050501702,0.0007843198,0.0005564089,0.00007008104,0.00071922597,0.0023419973,0.0026372687],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040254974,0.0007104089,0.0000037836567,0.057502523,0.0020018537,0.00025539525,0.000018096023,2.168902e-7,5.847236e-7,0.000024447369,0.5496203,0.38982219],"study_design_scores_gemma":[0.0022608764,0.0006500981,0.0000055163214,0.11301811,0.0106675085,0.0006027561,0.000015657235,0.0000032030305,0.0000018361445,0.000012581836,0.8722028,0.00055904157],"about_ca_topic_score_codex":0.000003679209,"about_ca_topic_score_gemma":0.0000029083922,"teacher_disagreement_score":0.38926312,"about_ca_system_score_codex":0.00041346118,"about_ca_system_score_gemma":0.0012987786,"threshold_uncertainty_score":0.99995965},"labels":[],"label_agreement":null},{"id":"W2462927708","doi":"10.1080/17512433.2016.1206467","title":"Tavaborole – a treatment for onychomycosis of the toenails","year":2016,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Nail (fastener); Dermatology; Nail disease; Pharmacodynamics; Antifungal; Adverse effect; Antifungal drugs; Intensive care medicine; Drug; Terbinafine; Pharmacokinetics; Pharmacology; Itraconazole; Psoriasis","score_opus":0.1985790396800821,"score_gpt":0.6048676893210374,"score_spread":0.40628864964095535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462927708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000046250084,0.98893094,0.000005334841,0.0013107609,0.0025286137,0.0061671473,0.00045881546,0.000014105278,0.00057964877],"genre_scores_gemma":[0.0000057906723,0.9924671,0.0002272644,0.0026920068,0.0015807005,0.0018339184,0.0000723099,0.00005503745,0.001065892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954719,0.000658907,0.00280141,0.00052838883,0.00023530838,0.00030410293],"domain_scores_gemma":[0.9947581,0.0021475407,0.0018556843,0.00075540994,0.00022842038,0.0002547936],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049817015,0.0004696899,0.006272355,0.0000565959,0.000035968373,0.0000015674276,0.00035823666,0.00030228123,0.0013051529],"category_scores_gemma":[0.0006348493,0.0001950597,0.005568143,0.00018873782,0.00026881523,0.00002303198,0.000095060575,0.00016282027,0.00005543875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012589592,0.001532401,0.00002840792,0.06808577,0.0021498986,0.0000061521355,0.00000303398,1.0400867e-9,0.0000013115416,0.00001859155,0.087349586,0.84069896],"study_design_scores_gemma":[0.0031779895,0.0011456036,0.000030437312,0.12185536,0.008538232,0.0000131396955,6.436167e-7,1.6681877e-7,0.000019984678,0.000010613518,0.8650785,0.00012933744],"about_ca_topic_score_codex":0.000008519086,"about_ca_topic_score_gemma":4.6563065e-7,"teacher_disagreement_score":0.8405696,"about_ca_system_score_codex":0.00013066024,"about_ca_system_score_gemma":0.0011384274,"threshold_uncertainty_score":0.9996078},"labels":[],"label_agreement":null},{"id":"W2522764002","doi":"10.1080/17512433.2016.1238762","title":"Herbal medicines: challenges in the modern world. Part 4. Canada and United States","year":2016,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Alternative medicine; Product (mathematics); Traditional medicine; Legislature; Quality (philosophy); Family medicine; Political science","score_opus":0.2934660403446119,"score_gpt":0.555482747077806,"score_spread":0.2620167067331941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522764002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017735952,0.96553373,0.000001352213,0.029586848,0.0022387085,0.0016301983,0.000049921782,0.000009530419,0.0009319499],"genre_scores_gemma":[0.000007619657,0.9721154,0.000016795364,0.023270763,0.003908683,0.0002938489,0.00014130364,0.000024979508,0.00022060795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941513,0.0018210341,0.0027134935,0.0005308434,0.00043486,0.0003484666],"domain_scores_gemma":[0.9911833,0.007314916,0.00083012244,0.0003556518,0.00013561592,0.00018044192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024738158,0.00045642757,0.004774634,0.00016030905,0.000039510276,0.0000014535814,0.0003696862,0.000049668346,0.0008205174],"category_scores_gemma":[0.0008587525,0.00020332457,0.00035701733,0.00032066688,0.0005200457,0.000023792123,0.00017593321,0.0007309258,0.000003875859],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027051772,0.00012012988,0.000054360695,0.04803727,0.0004621504,0.00014858728,0.00008630396,5.2018545e-9,2.9496029e-8,0.000017131568,0.18833023,0.76271677],"study_design_scores_gemma":[0.001216367,0.00035136487,0.000046235513,0.13950291,0.000859927,0.000052913434,0.00008747206,0.0000019903603,1.0588913e-7,0.000032170152,0.8576953,0.0001532498],"about_ca_topic_score_codex":0.0065744976,"about_ca_topic_score_gemma":0.025777636,"teacher_disagreement_score":0.7625635,"about_ca_system_score_codex":0.00007136862,"about_ca_system_score_gemma":0.0006149918,"threshold_uncertainty_score":0.9938718},"labels":[],"label_agreement":null},{"id":"W2522925890","doi":"10.1080/17512433.2016.1240029","title":"Methodological issues associated with clinical trials in neuropathic pain","year":2016,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Neuropathic pain; Clinical trial; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.49701399464965657,"score_gpt":0.6365394924654014,"score_spread":0.13952549781574486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522925890","genre_codex":"editorial","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044715736,0.042094972,0.0021365248,0.008372614,0.94204336,0.0037424339,0.000117407086,0.00017085193,0.0012771119],"genre_scores_gemma":[0.00009107569,0.49807447,0.0002703147,0.016744466,0.4835689,0.0003001831,0.00005000545,0.000066655884,0.0008339197],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.41140077,0.5756845,0.008942092,0.0019167386,0.0012597223,0.0007962197],"domain_scores_gemma":[0.09275362,0.89883894,0.0068393582,0.0008542412,0.00031511922,0.00039871313],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.6012179,0.00081755733,0.010514445,0.00023602735,0.00006993871,0.000025626112,0.0018288407,0.0021779502,0.0018644985],"category_scores_gemma":[0.92113876,0.00047202175,0.0020393368,0.0006087465,0.0012003769,0.0001356582,0.00045815978,0.0039381906,0.00016100277],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011673087,0.000725331,0.00023812181,0.0015750611,0.0001493093,0.0004490658,0.0000068377544,2.4847716e-7,0.00036039908,0.000015355703,0.8909675,0.104345486],"study_design_scores_gemma":[0.0035556818,0.001569656,0.00007419808,0.01105017,0.00035323066,0.0000012460629,0.0000011506553,0.00014653552,0.00017530001,0.00012229565,0.9824058,0.0005447303],"about_ca_topic_score_codex":0.000009256432,"about_ca_topic_score_gemma":0.000004730103,"teacher_disagreement_score":0.45847446,"about_ca_system_score_codex":0.00006746611,"about_ca_system_score_gemma":0.00058167113,"threshold_uncertainty_score":0.99977314},"labels":[],"label_agreement":null},{"id":"W2556384452","doi":"10.1080/17512433.2017.1260000","title":"Elosulfase alfa (BMN 110) for the treatment of mucopolysaccharidosis IVA (Morquio A Syndrome)","year":2016,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"BioMarin Pharmaceutical","keywords":"Medicine; Mucopolysaccharidosis; Internal medicine; Pediatrics","score_opus":0.20244798703558614,"score_gpt":0.5723343688873195,"score_spread":0.36988638185173334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556384452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021052183,0.98179,0.00006579464,0.0040829955,0.0028745483,0.01065031,0.0002680329,0.00003287107,0.00021439414],"genre_scores_gemma":[0.000009805292,0.9898603,0.0003447125,0.0022165545,0.0021116913,0.0040056636,0.00010509083,0.00012956487,0.0012166349],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99150157,0.0014043947,0.004727642,0.0009755332,0.0006651662,0.00072571967],"domain_scores_gemma":[0.9850066,0.010568791,0.0021268714,0.0012637441,0.0005712131,0.00046279974],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021951234,0.0007845355,0.00974228,0.00021146366,0.00009462272,0.000005648812,0.00097565685,0.0006376166,0.0053278776],"category_scores_gemma":[0.0022428208,0.00036948765,0.005604538,0.0005098964,0.00096876384,0.000053134987,0.00019145574,0.0005232803,0.00021281667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024480541,0.0020518345,0.000008340974,0.09049996,0.0030019165,0.00009553895,0.000022398563,6.2501955e-9,0.000008634832,0.000015899863,0.06903449,0.8350162],"study_design_scores_gemma":[0.003553422,0.003984401,0.0000062927,0.060263775,0.005307226,0.00018643236,0.000007269488,0.0000032414978,0.00004130902,0.000008191459,0.9263517,0.00028671915],"about_ca_topic_score_codex":0.000051418006,"about_ca_topic_score_gemma":0.0000017676006,"teacher_disagreement_score":0.8573172,"about_ca_system_score_codex":0.0002701261,"about_ca_system_score_gemma":0.0016459776,"threshold_uncertainty_score":0.9998757},"labels":[],"label_agreement":null},{"id":"W2561783875","doi":"10.1080/17512433.2017.1274651","title":"Update and trends on pharmacokinetic studies in patients with impaired renal function: practical insight into application of the FDA and EMA guidelines","year":2016,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Renal function; Impaired renal function; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.1340074352245196,"score_gpt":0.5498879234359803,"score_spread":0.4158804882114606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561783875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003570275,0.9928472,0.0000043035457,0.004574866,0.0006151718,0.0014961805,0.000020092097,0.000010873311,0.00007425815],"genre_scores_gemma":[0.00031042122,0.9903376,0.00014681196,0.007971792,0.000801196,0.00032273933,0.000052123378,0.000028452587,0.000028851342],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959386,0.0006725743,0.0023323845,0.00054819114,0.00031421438,0.00019403551],"domain_scores_gemma":[0.9966063,0.0011666118,0.0012658625,0.00037252562,0.0003748614,0.00021387245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008802993,0.0003722379,0.0031703725,0.0001325855,0.000032775388,0.0000022205966,0.00013023101,0.00019020382,0.00017558907],"category_scores_gemma":[0.0012155845,0.00016906136,0.00037030398,0.00033933716,0.00068773713,0.000059304148,0.00018417278,0.00038389885,0.000005905925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046211825,0.00053049583,0.0006154194,0.036801048,0.00072619726,0.0000036832885,0.000013108317,1.713621e-8,0.0000017878626,0.000019387571,0.043714844,0.9171119],"study_design_scores_gemma":[0.004106903,0.0008809044,0.0012021895,0.06281851,0.0029130813,0.0000063572447,0.0000022849495,0.0000041335725,0.0000057554994,0.000015159959,0.9278849,0.00015981575],"about_ca_topic_score_codex":0.0000028438412,"about_ca_topic_score_gemma":8.266862e-7,"teacher_disagreement_score":0.9169521,"about_ca_system_score_codex":0.000057865298,"about_ca_system_score_gemma":0.0003932152,"threshold_uncertainty_score":0.6894122},"labels":[],"label_agreement":null},{"id":"W2888588658","doi":"10.1080/17512433.2018.1516142","title":"Opioids in Ontario: the current state of affairs and a path forward","year":2018,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; St. Michael's Hospital","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Opioid; Current (fluid); Path (computing); State (computer science); Opioid epidemic; Internal medicine","score_opus":0.03615059706723368,"score_gpt":0.46373911014355446,"score_spread":0.4275885130763208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888588658","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030150467,0.37032622,0.0000037310858,0.0013165595,0.6224336,0.0023039384,0.00007773548,0.000012679239,0.0005105097],"genre_scores_gemma":[0.0006080865,0.7937252,0.00026799832,0.0008638897,0.20367187,0.00033812414,0.00020422268,0.000045015335,0.00027560932],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949016,0.00069981493,0.002804472,0.0006307541,0.00061619893,0.00034715512],"domain_scores_gemma":[0.9950199,0.0026022806,0.0012002713,0.00055140204,0.00042971424,0.00019643908],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020610932,0.00041669785,0.0030651398,0.00009182878,0.000022843771,0.0000032766995,0.00034610557,0.00030039137,0.0004942151],"category_scores_gemma":[0.0017094525,0.00025176178,0.00058402197,0.0001489414,0.0006489536,0.000033963206,0.00026646038,0.001712655,0.000018236033],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051261624,0.0011425032,0.00096619065,0.0071610794,0.00034663125,0.000018936627,0.0003791843,3.8604146e-8,0.000004610925,0.000001087232,0.8903804,0.099086754],"study_design_scores_gemma":[0.003990525,0.0017669906,0.002786849,0.011761224,0.00070201204,0.0000016942207,0.000014291819,0.0000045599095,0.000023057704,0.000058537968,0.9787132,0.00017707034],"about_ca_topic_score_codex":0.0020753143,"about_ca_topic_score_gemma":0.0024447253,"teacher_disagreement_score":0.42339897,"about_ca_system_score_codex":0.00015675348,"about_ca_system_score_gemma":0.0025641453,"threshold_uncertainty_score":0.99999344},"labels":[],"label_agreement":null},{"id":"W3005838166","doi":"10.1080/17512433.2020.1730812","title":"A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review","year":2020,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Nova Scotia Health Authority; Dalhousie University","funders":"National Institute on Aging; Medical Research Council; National Health and Medical Research Council; Mitacs","keywords":"Deprescribing; Medicine; Psychological intervention; Polypharmacy; Health care; Intervention (counseling); Nursing; Intensive care medicine","score_opus":0.2942812299582992,"score_gpt":0.5958405295606356,"score_spread":0.3015592996023364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005838166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029387278,0.9749363,0.000015419422,0.011593572,0.00092662504,0.012221006,0.00006924866,0.000020743097,0.00018767492],"genre_scores_gemma":[0.00020368939,0.9724882,0.00015697483,0.02518056,0.0006217685,0.001229344,0.00006133217,0.000052704163,0.000005430008],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98816365,0.003723619,0.005880011,0.0009874613,0.0005855179,0.00065974833],"domain_scores_gemma":[0.9911654,0.0040951343,0.0035535917,0.0004529046,0.0002905958,0.00044237165],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005082571,0.000623262,0.008864737,0.00007980329,0.00011791162,0.00001482764,0.0004973246,0.00023128827,0.000054860382],"category_scores_gemma":[0.0022814232,0.0003622768,0.0009874414,0.00039996096,0.00021116095,0.000101371144,0.000680421,0.0014603015,0.000005496747],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071133065,0.00017996087,0.000033623553,0.56338465,0.00035442112,0.000008372163,0.005112897,1.5406942e-8,9.5205124e-8,0.000018036058,0.006906105,0.4239307],"study_design_scores_gemma":[0.00097282155,0.00022023391,0.000020435358,0.38894346,0.0008240403,0.000032614756,0.0022472462,0.000016326167,3.632849e-7,2.0903751e-7,0.606555,0.00016727447],"about_ca_topic_score_codex":0.00003500412,"about_ca_topic_score_gemma":0.000004047694,"teacher_disagreement_score":0.59964883,"about_ca_system_score_codex":0.00012270469,"about_ca_system_score_gemma":0.00037986418,"threshold_uncertainty_score":0.99988294},"labels":[],"label_agreement":null},{"id":"W3016572994","doi":"10.1080/17512433.2020.1758063","title":"Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut","year":2020,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Gut flora; Dysbiosis; Bacteroides fragilis; Context (archaeology); Cancer; Biomarker; Fusobacterium nucleatum; Clinical trial; Disease; Immune system; Microbiome; Colorectal cancer; Immunology; Oncology; Bioinformatics; Internal medicine; Antibiotics; Biology; Periodontitis; Microbiology","score_opus":0.09264462083708122,"score_gpt":0.5159903345968604,"score_spread":0.42334571375977914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016572994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096213026,0.9343515,7.0018734e-7,0.059131503,0.0018134059,0.0034361018,0.00025398616,0.0000061037617,0.00004458338],"genre_scores_gemma":[0.00030927325,0.9335087,0.000009337896,0.06377936,0.0015204941,0.0005777742,0.000053911554,0.000045949946,0.0001952192],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98798627,0.008321967,0.0022252242,0.0008097968,0.00020728017,0.00044946553],"domain_scores_gemma":[0.9960756,0.0020254964,0.0007535546,0.00086301245,0.00010611216,0.00017624421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005961205,0.00053394056,0.0028533405,0.00003952848,0.000121264246,0.000019255585,0.0015361295,0.0005065336,0.000163678],"category_scores_gemma":[0.0004493283,0.00022004206,0.00094722246,0.00033521405,0.00043034423,0.000002343552,0.0004166492,0.0009959053,0.0000130789695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070437056,0.0002441937,0.00024137372,0.01556124,0.00089399505,0.00004421832,0.00047448854,1.2964166e-7,0.001242686,0.000008788335,0.60183406,0.37875044],"study_design_scores_gemma":[0.0007636036,0.00031186643,0.00028013025,0.0059256717,0.00026225467,0.000106653875,0.000032183452,2.6187485e-7,0.00000949621,5.5778423e-7,0.9920724,0.00023494221],"about_ca_topic_score_codex":0.00012827423,"about_ca_topic_score_gemma":0.00005120584,"teacher_disagreement_score":0.3902383,"about_ca_system_score_codex":0.000037911705,"about_ca_system_score_gemma":0.0011037849,"threshold_uncertainty_score":0.8973054},"labels":[],"label_agreement":null},{"id":"W3031742716","doi":"10.1080/17512433.2020.1772054","title":"Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments","year":2020,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Psychotherapist; Psilocybin; Perspective (graphical); Psychology; Hallucinogen; Psychopharmacology; Hypnosis; Psychopathology; MEDLINE; Neurochemical; Medicine; Psychiatry; Alternative medicine; Neuroscience","score_opus":0.19465118775830936,"score_gpt":0.5881763824918772,"score_spread":0.39352519473356784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031742716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030669085,0.970846,0.000087460656,0.0057720966,0.012159918,0.0039910707,0.00017194815,0.0001509935,0.0067898505],"genre_scores_gemma":[0.0000034052025,0.94902176,0.0014986,0.04398841,0.0028723162,0.0017946388,0.000045354653,0.0002596283,0.00051587063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98745924,0.0035208813,0.005431019,0.0023450553,0.00037005922,0.0008737581],"domain_scores_gemma":[0.9925149,0.0025237931,0.0031755946,0.00089338276,0.0001963486,0.00069595844],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0020080057,0.0016126875,0.009500204,0.00029840955,0.0001976285,0.000033064098,0.0009549276,0.0011706984,0.004070412],"category_scores_gemma":[0.00009631122,0.0011881086,0.0017414386,0.0007687049,0.0011237926,0.000080019476,0.000093839706,0.0016508703,0.000183234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005389065,0.0012072815,0.000040247807,0.010090716,0.0050255028,0.000030576233,0.0003768564,1.6718664e-9,0.000008685438,0.0006204817,0.23178306,0.7502777],"study_design_scores_gemma":[0.0076595806,0.0014873865,0.000049140977,0.017196093,0.0019884724,0.00011857857,0.00004504739,0.0000039901547,6.117292e-7,0.0003456456,0.9702058,0.00089967356],"about_ca_topic_score_codex":0.000037981943,"about_ca_topic_score_gemma":0.000008171929,"teacher_disagreement_score":0.749378,"about_ca_system_score_codex":0.00004674234,"about_ca_system_score_gemma":0.00025873168,"threshold_uncertainty_score":0.9996621},"labels":[],"label_agreement":null},{"id":"W3094092946","doi":"10.1080/17512433.2020.1841633","title":"Managing blood disorders during the Covid-19 pandemic: current pharmacological insights","year":2020,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Disease; Intensive care medicine; Virology; Outbreak; Infectious disease (medical specialty); Pathology","score_opus":0.23019505128730655,"score_gpt":0.5858739940751676,"score_spread":0.35567894278786105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094092946","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042859852,0.39543486,0.0006095129,0.5530178,0.0029265007,0.0041477312,0.000016874506,0.00030991578,0.00067694293],"genre_scores_gemma":[0.18442549,0.61701304,0.00007395325,0.19583654,0.0023512286,0.00022920717,0.0000066573148,0.000021256892,0.000042655232],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932998,0.0018955134,0.002511136,0.00092537946,0.00074945483,0.00061876053],"domain_scores_gemma":[0.97518915,0.021572614,0.000760325,0.0004711763,0.00026693003,0.0017398046],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026022957,0.00037102692,0.0019982476,0.00006319552,0.00023606124,0.000007443112,0.0007795049,0.00016354675,0.0025899373],"category_scores_gemma":[0.05534844,0.00021516043,0.0010239931,0.0005815821,0.0013334996,0.000074997355,0.0009885782,0.0019343453,0.0001020293],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061765644,0.007108106,0.14610937,0.091455705,0.005108495,0.0007614684,0.0014021549,0.000086810855,0.011926542,0.00022771805,0.43813235,0.29150474],"study_design_scores_gemma":[0.0068625472,0.0008907201,0.0049093524,0.00071738625,0.0008595039,0.000008305333,0.000025866508,0.00040161447,0.00016090128,0.00015102666,0.98476744,0.00024535865],"about_ca_topic_score_codex":0.000015538773,"about_ca_topic_score_gemma":0.0000020196564,"teacher_disagreement_score":0.5466351,"about_ca_system_score_codex":0.00009216239,"about_ca_system_score_gemma":0.0006726898,"threshold_uncertainty_score":0.99832183},"labels":[],"label_agreement":null},{"id":"W3111582504","doi":"10.1080/17512433.2021.1863784","title":"Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and docosahexaenoic acid in the prevention of cardiovascular diseases: a review of the state-of-the-art","year":2020,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Eicosapentaenoic acid; Docosahexaenoic acid; Hypertriglyceridemia; Polyunsaturated fatty acid; Medicine; Fish oil; Pharmacology; Omega 3 fatty acid; Internal medicine; Fatty acid; Biochemistry; Chemistry; Biology; Cholesterol; Triglyceride","score_opus":0.0842247830639177,"score_gpt":0.4799734632208405,"score_spread":0.39574868015692277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111582504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000099431,0.9840992,0.000016175665,0.0054380465,0.001916693,0.008203557,0.0001421679,0.000012951269,0.00007174745],"genre_scores_gemma":[0.0003698482,0.99276745,0.00012393799,0.005820465,0.00043119997,0.000353834,0.00006450462,0.00006129254,0.0000074352943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9767946,0.015343808,0.0051935883,0.00081818714,0.0012671432,0.0005826688],"domain_scores_gemma":[0.9926814,0.0020030863,0.003305931,0.0014424269,0.00031727226,0.00024988016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006394709,0.00064488087,0.0074675707,0.00015096676,0.00012472199,0.000011233572,0.0018494996,0.00031666053,0.0001358664],"category_scores_gemma":[0.0036258558,0.00032159055,0.004598504,0.001725517,0.0010521843,0.000117322306,0.000520684,0.002032087,0.000011198156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020195014,0.00049034134,0.000015173917,0.31411105,0.00065528246,0.0000072853845,0.000058030982,3.125196e-7,0.00007233969,0.0000057454567,0.007174793,0.6772077],"study_design_scores_gemma":[0.0009686913,0.0006310771,0.000110741996,0.28557378,0.00246771,0.000020137597,0.0000069298853,0.0000037273867,0.0005869886,0.000029337445,0.709403,0.00019793991],"about_ca_topic_score_codex":0.0000320876,"about_ca_topic_score_gemma":0.000007047907,"teacher_disagreement_score":0.7022282,"about_ca_system_score_codex":0.00014581557,"about_ca_system_score_gemma":0.0011122199,"threshold_uncertainty_score":0.9999236},"labels":[],"label_agreement":null},{"id":"W3117036619","doi":"10.1080/17512433.2021.1865798","title":"Reliance: a smarter way of regulating medical products - The IPRP survey","year":2020,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Quality (philosophy); Regulatory authority; Product (mathematics); Business; Regulatory science; Medicine; Public relations; Public administration; Political science","score_opus":0.17774188390405873,"score_gpt":0.5192638689955099,"score_spread":0.34152198509145115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117036619","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02027044,0.11186333,0.00022896491,0.8623158,0.0032011322,0.0012853371,0.000010041156,0.000036828835,0.0007881771],"genre_scores_gemma":[0.59189266,0.21817036,0.0013114234,0.18247479,0.005861327,0.000041122785,0.00007055247,0.00003244454,0.0001453175],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99537873,0.0012818112,0.002027729,0.00036042466,0.0007556188,0.0001956969],"domain_scores_gemma":[0.99635655,0.0018172673,0.00065563316,0.00029717886,0.0005210547,0.00035234325],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006813857,0.00013779286,0.0011676933,0.000019698096,0.000035825786,0.0000014787082,0.00028386316,0.00032204785,0.0018377972],"category_scores_gemma":[0.01095071,0.00007297854,0.00027356375,0.0004585442,0.0016903093,0.00002848192,0.00013588347,0.00082085154,0.000019193565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075852376,0.0006486667,0.0028420647,0.011853365,0.00034740072,0.000024261124,0.00041122138,4.0664943e-7,0.0061232783,0.00028612,0.7118559,0.2648488],"study_design_scores_gemma":[0.0041223713,0.0014105277,0.09487628,0.0076191793,0.00030322385,0.000035768808,0.000026713014,0.0023279926,0.003202132,0.00009651341,0.8857579,0.00022138098],"about_ca_topic_score_codex":0.000023782452,"about_ca_topic_score_gemma":0.0000019427932,"teacher_disagreement_score":0.679841,"about_ca_system_score_codex":0.000008184166,"about_ca_system_score_gemma":0.0005106681,"threshold_uncertainty_score":0.99907464},"labels":[],"label_agreement":null},{"id":"W3207599934","doi":"10.1080/17512433.2022.1987883","title":"Comparison of the registration process of the medicines control authority of Zimbabwe with Australia, Canada, Singapore, and Switzerland: benchmarking best practices","year":2021,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bill and Melinda Gates Foundation","keywords":"Benchmarking; Medicine; Best practice; Control (management); Process (computing); Optometry; Management; Marketing; Business","score_opus":0.23367907985036063,"score_gpt":0.5807938342554807,"score_spread":0.3471147544051201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207599934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.920194,0.041723527,0.00004451721,0.035324343,0.00095698965,0.00083745527,0.000021700826,0.0000037848047,0.0008936918],"genre_scores_gemma":[0.9884944,0.0059298966,0.00011252354,0.005052457,0.00032763917,0.000011905869,0.000004194475,0.0000055609553,0.00006141392],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965318,0.00088509504,0.0017228009,0.00021610345,0.0005035567,0.00014063218],"domain_scores_gemma":[0.994306,0.0018563181,0.0028479062,0.00023544165,0.0006610841,0.00009324246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019353493,0.00012496636,0.0012011696,0.000011739603,0.000047567188,0.0000018165947,0.0001813578,0.00008741665,0.00013206988],"category_scores_gemma":[0.0032834695,0.000065233246,0.0001361845,0.00021950499,0.00065725256,0.00005097614,0.000048904312,0.00046600503,6.383782e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029495056,0.0036152054,0.81852204,0.060565323,0.0013222876,0.000038480142,0.0014062301,0.000023861468,0.05582832,0.00044317677,0.02612161,0.029163962],"study_design_scores_gemma":[0.022682017,0.00448764,0.299954,0.08221738,0.010980294,0.00037815073,0.004732449,0.0034363982,0.40318856,0.0002632227,0.16691136,0.0007685395],"about_ca_topic_score_codex":0.0070254286,"about_ca_topic_score_gemma":0.008429235,"teacher_disagreement_score":0.51856804,"about_ca_system_score_codex":0.000016358497,"about_ca_system_score_gemma":0.0010808172,"threshold_uncertainty_score":0.9995869},"labels":[],"label_agreement":null},{"id":"W4200402274","doi":"10.1080/17512433.2022.2017771","title":"UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions","year":2021,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cannabis; Chronic pain; Brief Pain Inventory; Visual analogue scale; Nausea; Adverse effect; Cannabidiol; Quality of life (healthcare); McGill Pain Questionnaire; Physical therapy; Internal medicine; Psychiatry","score_opus":0.09424217047519787,"score_gpt":0.5619543234154374,"score_spread":0.4677121529402395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200402274","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35114196,0.24401246,0.0009902479,0.39300877,0.004722443,0.0040969737,0.0010809525,0.0000646261,0.00088155956],"genre_scores_gemma":[0.31140047,0.58605444,0.001169242,0.086706996,0.005399614,0.0012602772,0.0019497302,0.000113772054,0.0059454856],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9890766,0.0028414417,0.0054234816,0.0008265196,0.0012867713,0.00054518174],"domain_scores_gemma":[0.99256784,0.00148055,0.0015795066,0.0010520614,0.002268336,0.0010517159],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.013484058,0.0003297486,0.0053394157,0.0002644009,0.00006441891,0.000003910575,0.000597795,0.0005495167,0.016338624],"category_scores_gemma":[0.01781093,0.0002422759,0.003089236,0.0011445159,0.0018507335,0.000053662927,0.00013957753,0.0008458239,0.0000023118027],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008277402,0.0027517835,0.07893691,0.003116907,0.0062044547,0.00010899021,0.00007171997,0.0000027882566,0.00089106295,0.00018727744,0.81375,0.0931503],"study_design_scores_gemma":[0.009498936,0.0053873183,0.24273475,0.0015624965,0.0035577102,0.00002967805,0.00016964108,0.0013980038,0.0017441564,0.00004009649,0.73357344,0.00030376867],"about_ca_topic_score_codex":0.0005106817,"about_ca_topic_score_gemma":0.00035975795,"teacher_disagreement_score":0.34204194,"about_ca_system_score_codex":0.00008484739,"about_ca_system_score_gemma":0.0066573448,"threshold_uncertainty_score":0.99897397},"labels":[],"label_agreement":null},{"id":"W4220821209","doi":"10.1080/17512433.2022.2054413","title":"Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause","year":2022,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Drospirenone; Menopause; Tolerability; Estrogen; Estrogen receptor; Breast cancer; Internal medicine; Pharmacology; Oncology; Endocrinology; Cancer; Adverse effect","score_opus":0.04527136181481349,"score_gpt":0.45804086161140084,"score_spread":0.41276949979658734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220821209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020394512,0.99319965,0.000026246671,0.00006111616,0.000598808,0.0038447117,0.00013236841,0.0000037356426,0.000093935836],"genre_scores_gemma":[0.0004044795,0.99753994,0.000572841,0.00019075016,0.00025459225,0.0007061575,0.00026266158,0.00003935705,0.000029220577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948487,0.001782506,0.0025488513,0.00043307644,0.00017755668,0.00020925238],"domain_scores_gemma":[0.9948424,0.0014254809,0.0031235502,0.00033017527,0.00020612267,0.00007223902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025877014,0.00031762474,0.003494604,0.00005706988,0.000040061816,0.000001803512,0.00038745615,0.0003931061,0.000088808294],"category_scores_gemma":[0.0011124888,0.00019593153,0.0011076138,0.00016623885,0.00082941994,0.0000049697596,0.0002540564,0.00038636778,4.2752814e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015017895,0.00067540904,0.00000810828,0.07554317,0.002765974,0.0000021989026,0.000053802047,4.2394484e-7,0.007284734,0.00015441349,0.0033190914,0.90869087],"study_design_scores_gemma":[0.004106213,0.0043224003,0.0000025874613,0.009083868,0.002885201,0.000029370762,0.000012147746,0.00001612126,0.003420661,0.000011123472,0.9758906,0.00021973853],"about_ca_topic_score_codex":0.0000051405354,"about_ca_topic_score_gemma":1.2664475e-7,"teacher_disagreement_score":0.9725715,"about_ca_system_score_codex":0.00001480331,"about_ca_system_score_gemma":0.0003934298,"threshold_uncertainty_score":0.7989856},"labels":[],"label_agreement":null},{"id":"W4224310469","doi":"10.1080/17512433.2022.2070473","title":"Pharmacological profile of once-weekly injectable semaglutide for chronic weight management","year":2022,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Novo Nordisk; National Institute for Health and Care Research","keywords":"Semaglutide; Medicine; Tolerability; Weight loss; Overweight; Weight management; Obesity; Pharmacology; Type 2 diabetes; Diabetes mellitus; Internal medicine; Liraglutide; Adverse effect; Endocrinology","score_opus":0.06276375467588204,"score_gpt":0.46045669976235126,"score_spread":0.39769294508646924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224310469","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.099081405,0.68408334,0.00069131906,0.053526066,0.02102447,0.039811265,0.00032749097,0.0004237209,0.101030916],"genre_scores_gemma":[0.2280006,0.60993004,0.02924512,0.07387186,0.0052599083,0.019535452,0.0006791722,0.00017312032,0.033304747],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99656713,0.00042176055,0.0016736572,0.00051326194,0.00039091875,0.0004332561],"domain_scores_gemma":[0.9982242,0.0005288227,0.0006486578,0.00029617097,0.00013150311,0.00017065657],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017012601,0.00024026397,0.0015584441,0.00010870277,0.00009003557,0.0000018065798,0.00035385328,0.00006333553,0.01212985],"category_scores_gemma":[0.00009063616,0.00018940866,0.0007127157,0.0003145911,0.00020626295,0.000038794664,0.0004880807,0.0002898302,0.000027420157],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091509667,0.0038689384,0.00040280653,0.009234249,0.00203767,0.00007010943,0.00002317614,0.000009058914,0.0025827514,0.000611245,0.8146304,0.16561453],"study_design_scores_gemma":[0.0085460935,0.004935403,0.0004503585,0.000660902,0.0018976793,0.0000068374807,0.000033197633,0.00043822403,0.005681697,0.000050187264,0.97712636,0.00017303714],"about_ca_topic_score_codex":0.0000042048664,"about_ca_topic_score_gemma":2.3020023e-7,"teacher_disagreement_score":0.1654415,"about_ca_system_score_codex":0.00017589139,"about_ca_system_score_gemma":0.00018438188,"threshold_uncertainty_score":0.9887732},"labels":[],"label_agreement":null},{"id":"W4283641162","doi":"10.1080/17512433.2022.2094768","title":"Safety and efficacy of therapies for chylomicronemia","year":2022,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Hypertriglyceridemia; Acute pancreatitis; Chylomicron; Pancreatitis; Apolipoprotein B; Pharmacology; Bioinformatics; Internal medicine; Triglyceride; Cholesterol; Lipoprotein; Very low-density lipoprotein; Biology","score_opus":0.05282777732241084,"score_gpt":0.4729195015658429,"score_spread":0.42009172424343205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283641162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0966923,0.87809277,0.00014807907,0.018072616,0.0032775071,0.0023365393,0.000060863487,0.000023829525,0.001295519],"genre_scores_gemma":[0.08970524,0.85634184,0.0031190447,0.048877396,0.0013448179,0.00019796105,0.000050561852,0.000027548387,0.00033558515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816906,0.00028824052,0.0010768608,0.00021021295,0.00012099984,0.0001346253],"domain_scores_gemma":[0.9981653,0.0011569447,0.00034464773,0.00016526712,0.00007881563,0.000088991066],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013932073,0.000097439166,0.0011229842,0.00003333271,0.000046050205,5.1588904e-7,0.0001132308,0.000043981596,0.0016924875],"category_scores_gemma":[0.00059784605,0.00007449139,0.00030968626,0.000090512694,0.00023235109,0.000018581719,0.00010781245,0.00017586665,0.0000013555056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007015124,0.0021122438,0.0024550613,0.007208829,0.00065657246,0.0000034848717,0.00052767206,0.0000013883847,0.025804685,0.0008085427,0.3746018,0.57880455],"study_design_scores_gemma":[0.008167936,0.0006652649,0.0046270764,0.00018708466,0.00025190017,0.0000072882926,0.00006488749,0.000015413541,0.0010182508,0.000029933735,0.9848943,0.00007068349],"about_ca_topic_score_codex":0.0000060917273,"about_ca_topic_score_gemma":1.0786655e-7,"teacher_disagreement_score":0.61029243,"about_ca_system_score_codex":0.000007152101,"about_ca_system_score_gemma":0.00013880277,"threshold_uncertainty_score":0.9992201},"labels":[],"label_agreement":null},{"id":"W4283713772","doi":"10.1080/17512433.2022.2092470","title":"Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis","year":2022,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aurinia (Canada)","funders":"","keywords":"Medicine; Calcineurin; Lupus nephritis; Pharmacodynamics; Pharmacology; Pharmacokinetics; Drug; Mycophenolate; Mycophenolic acid; Proteinuria; Clinical trial; Internal medicine; Kidney; Transplantation; Disease","score_opus":0.2687197206563499,"score_gpt":0.5653869755982474,"score_spread":0.29666725494189744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283713772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012362486,0.97492546,0.00002750108,0.0013147164,0.010331978,0.012846489,0.0002519283,0.00002952643,0.00026002887],"genre_scores_gemma":[7.497719e-7,0.9828618,0.00051262596,0.0014038034,0.005929868,0.0070858723,0.00016181891,0.00012606203,0.0019173609],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910875,0.0011428162,0.005623865,0.000847004,0.0007482677,0.00055056595],"domain_scores_gemma":[0.9817026,0.0143036125,0.0022475787,0.0011120546,0.00031599554,0.0003181198],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030313302,0.000637686,0.009642523,0.00018019344,0.000085739404,0.0000037219452,0.00074818236,0.00041690195,0.0031760896],"category_scores_gemma":[0.001927494,0.00035040296,0.0046970407,0.0005541174,0.0004904434,0.000026723323,0.00023272578,0.0007311838,0.000026278693],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020439799,0.0017967669,0.000022392609,0.20786709,0.0014462338,0.0000447151,0.000053942626,2.6762763e-8,0.0000053208773,0.000016211538,0.13462894,0.653914],"study_design_scores_gemma":[0.0045722523,0.0032416082,8.351528e-7,0.057244584,0.0036817677,0.0030085833,0.000024395864,0.000007084138,0.00001364832,0.0000013176391,0.92798686,0.00021705263],"about_ca_topic_score_codex":0.000033480555,"about_ca_topic_score_gemma":0.0000015209918,"teacher_disagreement_score":0.7933579,"about_ca_system_score_codex":0.00033563454,"about_ca_system_score_gemma":0.0017715826,"threshold_uncertainty_score":0.9998948},"labels":[],"label_agreement":null},{"id":"W4292448866","doi":"10.1080/17512433.2022.2088503","title":"Reliance is key to effective access and oversight of medical products in case of public health emergencies","year":2022,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Key (lock); Public health; Quality (philosophy); Business; Authorization; Medicine; Risk analysis (engineering); Pandemic; Coronavirus disease 2019 (COVID-19); Public relations; Computer security; Computer science; Political science","score_opus":0.3233802500915234,"score_gpt":0.6163913624562355,"score_spread":0.2930111123647121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292448866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6022427,0.14614035,0.000047842754,0.24812387,0.0012778675,0.0018228673,0.000035958798,0.0000120287805,0.00029652327],"genre_scores_gemma":[0.75706536,0.15074018,0.00019458862,0.091512956,0.0002882854,0.00015594978,0.000004697366,0.000010772288,0.000027201273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994703,0.0021457598,0.0019220923,0.00039343355,0.0005566584,0.00027908626],"domain_scores_gemma":[0.9972639,0.0013460941,0.0005673779,0.0002057337,0.00022485787,0.00039202312],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009651634,0.00012523335,0.0013932062,0.000108980734,0.000044486158,0.0000014486121,0.00028439384,0.00006802216,0.0023118262],"category_scores_gemma":[0.0050576404,0.00010568424,0.00014593608,0.00067505287,0.00030515622,0.00007980964,0.0005453818,0.0005980184,0.000001673832],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019433682,0.0067313625,0.022200106,0.06366367,0.0006596831,0.0011868874,0.006660104,0.0000019061124,0.0043721725,0.0008080571,0.400338,0.4914347],"study_design_scores_gemma":[0.006728446,0.0042508394,0.008126042,0.0059211194,0.00016785042,0.000622394,0.00073172816,0.0003760094,0.009418149,0.00006257502,0.9632853,0.00030954235],"about_ca_topic_score_codex":0.0002263257,"about_ca_topic_score_gemma":0.000008897388,"teacher_disagreement_score":0.56294733,"about_ca_system_score_codex":0.00005534745,"about_ca_system_score_gemma":0.0006071644,"threshold_uncertainty_score":0.9986002},"labels":[],"label_agreement":null},{"id":"W4387840848","doi":"10.1080/17512433.2023.2274538","title":"A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia","year":2023,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation; University of Ottawa; McMaster University; University of Toronto","funders":"","keywords":"Amisulpride; Medicine; Schizophrenia (object-oriented programming); Bipolar disorder; Narrative review; Depressive symptoms; Psychiatry; Major depressive disorder; Aripiprazole; Treatment of bipolar disorder; Internal medicine; Antipsychotic; Lithium (medication); Cognition","score_opus":0.14904308174160405,"score_gpt":0.5336761911223976,"score_spread":0.38463310938079354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387840848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031992365,0.9765054,0.00001972817,0.0002630487,0.001116138,0.017993731,0.00087397883,0.00002325569,0.0000054942475],"genre_scores_gemma":[0.00003683327,0.98866266,0.00045453556,0.0005931065,0.00024450084,0.009744003,0.000070420036,0.00012513835,0.00006883054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98919475,0.0018276221,0.0066051707,0.0014325874,0.0003855431,0.0005543359],"domain_scores_gemma":[0.9862111,0.0077501675,0.0047446005,0.0007758667,0.00029204943,0.00022619474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088598556,0.00096307305,0.011019713,0.0003244316,0.00005327281,0.000004513793,0.00076468947,0.00041594738,0.00014277069],"category_scores_gemma":[0.001645808,0.0006752627,0.0028440165,0.00077199517,0.00081885734,0.0001186754,0.000112128015,0.0002072373,0.000006943787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003351884,0.0019778542,0.000048542526,0.24438272,0.0002959477,0.000012774376,0.00020453343,2.4555928e-7,0.0022310815,0.000008139214,0.00077249383,0.74973047],"study_design_scores_gemma":[0.0060967617,0.0056414437,0.000018432,0.19765577,0.003298728,0.000019363039,0.000008841755,0.000008148276,0.008645485,0.000008454086,0.77812535,0.0004732445],"about_ca_topic_score_codex":0.000042670803,"about_ca_topic_score_gemma":0.0000073295137,"teacher_disagreement_score":0.7773528,"about_ca_system_score_codex":0.00014687631,"about_ca_system_score_gemma":0.00071714655,"threshold_uncertainty_score":0.99956983},"labels":[],"label_agreement":null},{"id":"W4387965390","doi":"10.1080/17512433.2023.2276309","title":"Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician’s perspective","year":2023,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cannabis; Medicine; Addiction; Psychiatry; Intervention (counseling); Perspective (graphical); Posttraumatic stress; Psychotherapist; Psychology","score_opus":0.3532513076443655,"score_gpt":0.5980582301905207,"score_spread":0.24480692254615521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387965390","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000017730141,0.8555964,0.0000016397037,0.13733803,0.00083541026,0.005044796,0.00005890987,0.00003857081,0.0010844722],"genre_scores_gemma":[0.0000024613955,0.98325104,0.00022553814,0.0053022313,0.004087348,0.0029869762,0.000033876502,0.000092768176,0.004017792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943243,0.0012519502,0.002567829,0.00089622336,0.00044406176,0.00051560375],"domain_scores_gemma":[0.99403393,0.0029835568,0.0011277609,0.000530177,0.00091450755,0.00041009326],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004173496,0.00050272077,0.0051595923,0.00015397134,0.00016891837,0.000012097009,0.00025218996,0.00041808278,0.0003565477],"category_scores_gemma":[0.005580528,0.0002583867,0.0011599193,0.0002662002,0.0012088756,0.000039847953,0.00012982287,0.001297776,0.000015140286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008379988,0.00014862063,8.74703e-7,0.070219085,0.0009771744,0.000056985093,0.00023210075,1.7615886e-8,2.5513492e-7,0.00047825385,0.36644644,0.5613564],"study_design_scores_gemma":[0.0015257346,0.0017937262,0.000033865643,0.06533726,0.0034050995,0.00030787208,0.0007563815,0.0000029411708,0.0000010998465,0.00008692818,0.92652327,0.00022582887],"about_ca_topic_score_codex":0.00009320746,"about_ca_topic_score_gemma":0.000118657044,"teacher_disagreement_score":0.5611306,"about_ca_system_score_codex":0.00011959933,"about_ca_system_score_gemma":0.0024616928,"threshold_uncertainty_score":0.9999868},"labels":[],"label_agreement":null},{"id":"W4389144356","doi":"10.1080/17512433.2023.2289543","title":"Novel insights into molecular and cellular aspects of delayed drug hypersensitivity reactions","year":2023,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; MEDLINE; Intensive care medicine; Drug development; Bioinformatics; Drug; Pharmacology","score_opus":0.12034599111117852,"score_gpt":0.4958279899350887,"score_spread":0.3754819988239102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389144356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000086369444,0.9867352,0.00008595604,0.0005995495,0.0029751188,0.0023252107,0.000027336218,0.00008875406,0.0070764716],"genre_scores_gemma":[0.0002608776,0.9958218,0.0009006741,0.0013058861,0.0010567696,0.00016559387,0.00014606054,0.000119471224,0.0002228918],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937461,0.0008677965,0.003714441,0.0008877081,0.0004400799,0.00034386752],"domain_scores_gemma":[0.9931433,0.0031474296,0.002073811,0.0007514363,0.00041284395,0.0004711656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015445325,0.00059593376,0.006865076,0.0003734475,0.00006419252,0.0000032068328,0.00023585344,0.00058845384,0.000044118235],"category_scores_gemma":[0.0021300465,0.00047414185,0.0019163648,0.0008443789,0.00058478996,0.00008050017,0.00027085035,0.0015099646,0.00011124926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001849897,0.0013283484,2.5790658e-7,0.1631621,0.002905858,0.00044769235,0.00007203457,2.4244866e-7,0.00794435,0.0006018643,0.002546752,0.820972],"study_design_scores_gemma":[0.0009223206,0.00009004932,0.0000033842498,0.06392703,0.0053726863,0.00020554451,0.000025650903,0.000010138647,0.0005291586,0.000044598095,0.92856,0.00030943673],"about_ca_topic_score_codex":0.00016939384,"about_ca_topic_score_gemma":0.000008830041,"teacher_disagreement_score":0.92601323,"about_ca_system_score_codex":0.00013031297,"about_ca_system_score_gemma":0.0011950086,"threshold_uncertainty_score":0.999771},"labels":[],"label_agreement":null},{"id":"W4391384708","doi":"10.1080/17512433.2024.2313616","title":"The effect of different levothyroxine administration regimens on thyroid hormone levels: a systematic review, pairwise, and network meta-analysis","year":2024,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Meta-analysis; Randomized controlled trial; Internal medicine; Levothyroxine; Confidence interval; Relative risk; Regimen; Publication bias; Thyroid","score_opus":0.13927712497230965,"score_gpt":0.5109321245402111,"score_spread":0.37165499956790143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391384708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029465257,0.98706603,0.0000073844317,0.0020614667,0.0006287411,0.00991009,0.00008140327,0.00003265137,0.00020930027],"genre_scores_gemma":[0.00010461144,0.9933773,0.000034659,0.0022931416,0.00045733707,0.0028046581,0.00017609625,0.00006892532,0.000683222],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9861927,0.0057277884,0.0061324798,0.00090650056,0.0006442405,0.0003962622],"domain_scores_gemma":[0.98759,0.007323679,0.003459945,0.0011820819,0.00015871538,0.0002855389],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0054076123,0.0009894831,0.025751902,0.00015053255,0.00008218364,0.000013182653,0.00038960908,0.00036827402,0.0001883651],"category_scores_gemma":[0.001815179,0.00039702404,0.0103484625,0.00089052686,0.00032962186,0.000028700993,0.0001634606,0.0008325645,0.00004102189],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112788504,0.00028688318,0.0000010844345,0.71457213,0.1847715,0.000043392574,0.000003375378,3.5932555e-8,3.1845903e-7,0.000027522503,0.078827776,0.021353185],"study_design_scores_gemma":[0.0006501377,0.0037459808,0.0000024762285,0.21619087,0.63142216,0.000032159624,9.2319067e-7,0.0000045654647,0.0000016770075,0.000005849363,0.14775647,0.00018672779],"about_ca_topic_score_codex":0.0000031445006,"about_ca_topic_score_gemma":0.0000025531222,"teacher_disagreement_score":0.49838126,"about_ca_system_score_codex":0.000061076404,"about_ca_system_score_gemma":0.00020951171,"threshold_uncertainty_score":0.9998482},"labels":[],"label_agreement":null},{"id":"W4392473314","doi":"10.1080/17512433.2024.2318465","title":"Exposure–efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn’s disease and ulcerative colitis","year":2024,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Crohn's disease; Disease; Colitis; Internal medicine; Inflammatory bowel disease; Gastroenterology","score_opus":0.03366104209284545,"score_gpt":0.41024959415369133,"score_spread":0.3765885520608459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392473314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9267179,0.07132881,0.00006517672,0.0005435421,0.00040360604,0.000666264,0.000053822703,0.000008955182,0.00021192478],"genre_scores_gemma":[0.9389944,0.059502013,0.00021496689,0.0008062832,0.0003070212,0.000061133236,0.000049329097,0.000014895707,0.000049924714],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99809253,0.00045653625,0.0008926798,0.00032531744,0.00008470361,0.00014821847],"domain_scores_gemma":[0.9989988,0.00043315595,0.00014026895,0.00016734272,0.00008740486,0.0001729786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050138205,0.0001324325,0.0003823,0.00005095871,0.000031146785,0.0000061335527,0.00008797886,0.00011458419,0.00008786936],"category_scores_gemma":[0.00089032867,0.00012203119,0.00012578837,0.00008079391,0.00030644157,0.000009222633,0.00008334014,0.00015682192,0.0000027023577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013562471,0.0026173966,0.09251173,0.026406512,0.0011542178,0.0051822197,0.0016697717,0.00009447465,0.008942982,0.013035222,0.037262272,0.79756075],"study_design_scores_gemma":[0.0012219117,0.0002940119,0.9848387,0.0010506037,0.00012877391,0.000033956498,0.000013164033,0.0002366511,0.00021521385,0.00035088943,0.011447727,0.00016838658],"about_ca_topic_score_codex":0.0000049375017,"about_ca_topic_score_gemma":0.000013992837,"teacher_disagreement_score":0.892327,"about_ca_system_score_codex":0.000011202405,"about_ca_system_score_gemma":0.00024895894,"threshold_uncertainty_score":0.49762875},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4394814052","doi":"10.1080/17512433.2024.2343913","title":"Engaging patients in conversations about deprescribing","year":2024,"lang":"en","type":"editorial","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; University of Ottawa; University of Waterloo","funders":"","keywords":"Deprescribing; Medicine; Polypharmacy; Intensive care medicine","score_opus":0.15684917259830164,"score_gpt":0.5650808202575986,"score_spread":0.408231647659297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394814052","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045481446,0.16281134,0.00000576871,0.0032015515,0.8281648,0.0014921806,0.00007892752,0.000049764687,0.0037408571],"genre_scores_gemma":[0.0009641093,0.5248109,0.00022026322,0.012705223,0.46028927,0.00011848122,0.00048771544,0.000060806113,0.0003432162],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938247,0.0011195638,0.0031162133,0.0007250744,0.00079680514,0.0004176205],"domain_scores_gemma":[0.98758316,0.010357285,0.0008924576,0.0003652405,0.00046115712,0.00034069043],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027274098,0.00039083688,0.002448867,0.0002024133,0.00003698735,0.000010794195,0.00031937714,0.0007304333,0.0017426017],"category_scores_gemma":[0.013000981,0.00031434753,0.00079836516,0.00032480824,0.00022616245,0.00013875133,0.00025989235,0.0038850787,0.00025274235],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028428267,0.0007217565,0.004117831,0.015750324,0.00033475965,0.000071349095,0.000070338545,2.2564919e-7,0.000010374935,0.000005877736,0.9625956,0.016037289],"study_design_scores_gemma":[0.0035987047,0.0003023149,0.0004460557,0.017665965,0.0009753181,0.000001251772,0.000009052887,0.00015648332,0.000034428507,0.000012330275,0.9765528,0.0002453284],"about_ca_topic_score_codex":0.00006905694,"about_ca_topic_score_gemma":0.000003314853,"teacher_disagreement_score":0.36787552,"about_ca_system_score_codex":0.00013176391,"about_ca_system_score_gemma":0.0007447027,"threshold_uncertainty_score":0.99993086},"labels":[],"label_agreement":null},{"id":"W4396854990","doi":"10.1080/17512433.2024.2355270","title":"Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks","year":2024,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Alberta Health; Alberta Health Services; Bruyère; University of Ottawa; University of British Columbia; University of Calgary; McGill University Health Centre","funders":"Health Canada","keywords":"Polypharmacy; Deprescribing; Medicine; Intensive care medicine; Medical emergency","score_opus":0.3037696699159056,"score_gpt":0.5820265566205958,"score_spread":0.2782568867046902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396854990","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2677519,0.65690935,0.0014890879,0.049238358,0.013239632,0.0024268997,0.00008150952,0.00009546354,0.008767814],"genre_scores_gemma":[0.78749186,0.20292208,0.000472386,0.0070412355,0.0017071655,0.000024190505,0.000025844394,0.000018801675,0.0002964404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974973,0.00041754093,0.0012552338,0.00030399833,0.00033104574,0.00019484392],"domain_scores_gemma":[0.99712557,0.0019859027,0.00036188503,0.00012178901,0.00023989427,0.00016495594],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021470995,0.00016067669,0.00064043264,0.00006612095,0.00004680508,0.00001072573,0.0001918422,0.00008341233,0.0024067892],"category_scores_gemma":[0.0010965475,0.0000923411,0.00052281085,0.00018157561,0.0002560759,0.00015234135,0.00024066331,0.0005489459,0.000014591461],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040850304,0.0012763588,0.019841766,0.0049501522,0.0066408888,0.00012209681,0.00038414248,0.00035380042,0.019783964,0.00042036423,0.4058144,0.53632706],"study_design_scores_gemma":[0.009388707,0.0014728846,0.051233348,0.010936017,0.0023289113,0.0008776734,0.00003577116,0.27930653,0.002620547,0.00023121426,0.64094394,0.00062444387],"about_ca_topic_score_codex":0.00005065163,"about_ca_topic_score_gemma":3.7992996e-7,"teacher_disagreement_score":0.5357026,"about_ca_system_score_codex":0.00006798412,"about_ca_system_score_gemma":0.00026247866,"threshold_uncertainty_score":0.9985052},"labels":[],"label_agreement":null},{"id":"W4398256177","doi":"10.1080/17512433.2024.2359955","title":"The effect of anticholinergic drugs on cognition of patients with Parkinson’s disease: a cohort study from the Egyptian population","year":2024,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Anticholinergic; Cognition; Disease; Parkinson's disease; Cohort; Anticholinergic agents; Population; Internal medicine; Psychiatry","score_opus":0.020087537303987726,"score_gpt":0.41689132635952963,"score_spread":0.3968037890555419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398256177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95748234,0.037432387,0.000005068582,0.0008602294,0.00095179374,0.0030655991,0.00010687857,0.000018120187,0.00007757346],"genre_scores_gemma":[0.9774693,0.020582655,0.00001817937,0.001099162,0.00029974047,0.0002696262,0.00022760064,0.000019764895,0.000013941476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704784,0.0010267689,0.00096068846,0.00034486817,0.00048283383,0.00013697679],"domain_scores_gemma":[0.9969752,0.0020444186,0.00039138438,0.000324412,0.00013178341,0.00013283154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010878037,0.00018585795,0.00088295876,0.000031036412,0.000053202068,0.0000045267925,0.00013326702,0.0000479306,0.00017141976],"category_scores_gemma":[0.00037741193,0.00007978546,0.00031546364,0.00017561096,0.00013677133,0.000035016845,0.000038495113,0.00018615149,0.000010559678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004947201,0.0021860853,0.942594,0.0011424518,0.001734734,0.00003097509,0.000053041913,0.0000011527333,0.00002350592,0.000011607626,0.0047769384,0.042498328],"study_design_scores_gemma":[0.00442913,0.0032062253,0.9653745,0.0032525996,0.0033516523,2.747342e-7,0.000009084713,0.00010084229,0.0002001853,0.0000180735,0.019984193,0.000073202355],"about_ca_topic_score_codex":0.000042805994,"about_ca_topic_score_gemma":0.0000022950485,"teacher_disagreement_score":0.042425126,"about_ca_system_score_codex":0.000023222035,"about_ca_system_score_gemma":0.00006913135,"threshold_uncertainty_score":0.32535565},"labels":[],"label_agreement":null},{"id":"W4400953751","doi":"10.1080/17512433.2024.2375449","title":"Somatic pharmacogenomics in the treatment prognosis of locally advanced rectal cancer patients: a narrative review of the literature","year":2024,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute","keywords":"Medicine; Pharmacogenomics; Colorectal cancer; Narrative review; Somatic cell; Oncology; Internal medicine; Intensive care medicine; Cancer; Pharmacology","score_opus":0.07208242355327657,"score_gpt":0.5248407174794154,"score_spread":0.45275829392613887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400953751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027555908,0.98387724,8.0281744e-8,0.0026240307,0.002357498,0.010267497,0.00027829205,0.000009720212,0.00031005868],"genre_scores_gemma":[0.00007078551,0.98930067,0.000059364105,0.0049055167,0.000500538,0.0049315183,0.00009072471,0.00004435925,0.00009654101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928167,0.0017622543,0.004082181,0.0006009949,0.0004458432,0.00029203005],"domain_scores_gemma":[0.99555534,0.0012057576,0.002211727,0.00045237265,0.00048746544,0.000087318054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009887796,0.0006662829,0.006933946,0.00009366177,0.000043179312,0.000003771227,0.0005082862,0.00022458928,0.00026573933],"category_scores_gemma":[0.0005265098,0.00026990453,0.0029021357,0.0010860347,0.0004108263,0.000041165225,0.00015416282,0.0007442201,0.0000043169134],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012469396,0.0018248707,0.00004555008,0.3756353,0.002000953,0.000016303185,0.0010364124,3.0954702e-8,0.0000013756475,0.0000018209586,0.017892636,0.60142004],"study_design_scores_gemma":[0.0010723635,0.0013418955,0.000023236937,0.4329599,0.006953543,0.000008695243,0.000028916233,6.113738e-7,0.000013534354,0.000002329498,0.55747676,0.000118187825],"about_ca_topic_score_codex":0.000019977417,"about_ca_topic_score_gemma":0.000012207143,"teacher_disagreement_score":0.60130185,"about_ca_system_score_codex":0.00033744684,"about_ca_system_score_gemma":0.0011698063,"threshold_uncertainty_score":0.9999753},"labels":[],"label_agreement":null},{"id":"W4401521828","doi":"10.1080/17512433.2024.2390927","title":"Drug related adverse event assessment in neonates in clinical trials and clinical care","year":2024,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; KU Leuven","keywords":"Medicine; Polypharmacy; Adverse effect; Adverse drug event; Drug; Intensive care medicine; Clinical trial; Seriousness; Pharmacotherapy; Pharmacology; Internal medicine","score_opus":0.3954129327834758,"score_gpt":0.701691288093323,"score_spread":0.30627835530984726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401521828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039787486,0.95685405,0.0000015836688,0.002007841,0.03265348,0.0056201257,0.00032109267,0.000116396404,0.0020275672],"genre_scores_gemma":[0.00039670154,0.98559827,0.00015253658,0.008153234,0.0036753556,0.0009791332,0.0003862461,0.00014774007,0.00051081565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.92777175,0.044260487,0.02406752,0.002307408,0.0004774549,0.0011153658],"domain_scores_gemma":[0.9624757,0.030358607,0.0051915688,0.0007107625,0.000249763,0.0010135942],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.060055755,0.001377511,0.016218042,0.00075103884,0.00010775311,0.00001623095,0.0012153606,0.0029164983,0.0028176964],"category_scores_gemma":[0.0061151437,0.0010625875,0.006296051,0.0012956853,0.0013782566,0.000249001,0.0008232229,0.014518944,0.00050511735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020804862,0.0021286476,0.0017150781,0.051892743,0.0022820744,0.0008023135,0.0001263981,0.0000047399526,0.000001673836,0.00009718391,0.10087345,0.83986765],"study_design_scores_gemma":[0.0059112916,0.00026002267,0.00024843786,0.04701645,0.008086899,0.00006033914,0.00013484269,0.0002097606,0.000002029566,0.000063517444,0.9371635,0.00084296026],"about_ca_topic_score_codex":0.000048307047,"about_ca_topic_score_gemma":0.000041947504,"teacher_disagreement_score":0.83902466,"about_ca_system_score_codex":0.0003967257,"about_ca_system_score_gemma":0.0032378016,"threshold_uncertainty_score":0.99989754},"labels":[],"label_agreement":null},{"id":"W4404727703","doi":"10.1080/17512433.2024.2433603","title":"Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pitavastatin; Rosuvastatin; Medicine; Atorvastatin; Meta-analysis; Type 2 Diabetes Mellitus; Statin; Diabetes mellitus; Internal medicine; Pharmacology; Endocrinology","score_opus":0.1150498640106041,"score_gpt":0.5001066843340876,"score_spread":0.38505682032348343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404727703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019557678,0.9861447,0.000073053765,0.0013737758,0.0001606907,0.011793466,0.00037449878,0.00003170338,0.000028528217],"genre_scores_gemma":[0.000008119697,0.98364705,0.0041721766,0.010040196,0.00019310461,0.0015136303,0.000119773795,0.00009034866,0.0002156165],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98597234,0.005061382,0.0065075685,0.001185509,0.00082281674,0.0004503837],"domain_scores_gemma":[0.9916094,0.0026055805,0.003175977,0.001216645,0.0004217114,0.0009707017],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.008677251,0.00090689113,0.037603647,0.00032780322,0.000043482643,0.000015495225,0.00031450856,0.00024546988,0.0007376918],"category_scores_gemma":[0.0024165758,0.00047907705,0.006532253,0.001484963,0.00030346884,0.000046527,0.00023003652,0.0009105379,0.000049607694],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019329816,0.00011503304,0.0000041385065,0.7332219,0.2152568,0.000027996168,0.00005111279,7.12707e-8,4.8903203e-8,0.0000041768376,0.016238973,0.035060424],"study_design_scores_gemma":[0.0003536541,0.0005460681,0.000004474162,0.22505438,0.58341956,0.00006453249,0.0000100861835,0.00000187339,6.8807634e-7,0.000004167322,0.19030364,0.00023687072],"about_ca_topic_score_codex":0.00019319162,"about_ca_topic_score_gemma":0.000011969537,"teacher_disagreement_score":0.5081675,"about_ca_system_score_codex":0.000044193814,"about_ca_system_score_gemma":0.001120058,"threshold_uncertainty_score":0.9997661},"labels":[],"label_agreement":null},{"id":"W4406870441","doi":"10.1080/17512433.2025.2459377","title":"The ketamine chameleon: history, pharmacology, and the contested value of experience","year":2025,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Medicine; Ketamine; Value (mathematics); Pharmacology; Clinical pharmacology; Anesthesia","score_opus":0.09890237821762422,"score_gpt":0.5332289331298158,"score_spread":0.4343265549121916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406870441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015649914,0.9800538,0.0000056452286,0.0053510414,0.0074965376,0.0053267214,0.00001576069,0.000038212947,0.0016966389],"genre_scores_gemma":[0.000023338089,0.98658645,0.00012751042,0.008591248,0.0012217043,0.0014626203,0.000032231885,0.000041006548,0.0019138752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98992723,0.004255531,0.0042188535,0.0007585603,0.00044212223,0.0003976851],"domain_scores_gemma":[0.97763044,0.018156057,0.002809992,0.0008578592,0.000319485,0.00022617965],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0034780002,0.00063572143,0.007571899,0.00010650012,0.00010270001,0.0000036264482,0.000878326,0.00047444535,0.0006853037],"category_scores_gemma":[0.0032519833,0.00028552077,0.0018108715,0.0002863138,0.0037961558,0.00004533228,0.00050698075,0.0011498416,0.0000122452675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005002824,0.00045835832,0.000014014099,0.06679865,0.0011455622,0.00003355303,0.00006364068,9.674145e-9,0.000013371979,0.0001710112,0.21689983,0.7139017],"study_design_scores_gemma":[0.0055855955,0.00039572804,0.00002212672,0.06887357,0.005913163,0.000084946754,0.000012278887,0.000008823592,0.000035175424,0.00000578433,0.9188834,0.00017942247],"about_ca_topic_score_codex":0.000022676888,"about_ca_topic_score_gemma":7.2494674e-7,"teacher_disagreement_score":0.7137223,"about_ca_system_score_codex":0.00014860238,"about_ca_system_score_gemma":0.0011917759,"threshold_uncertainty_score":0.9999597},"labels":[],"label_agreement":null},{"id":"W4408543281","doi":"10.1080/17512433.2025.2481868","title":"Scoping review of the availability and uptake of disease modifying therapies in children and adolescents with multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Disease; Fingolimod; Intensive care medicine; Immunology; Internal medicine","score_opus":0.10788692239457894,"score_gpt":0.4692321362050133,"score_spread":0.3613452138104344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408543281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4195131,0.5746536,0.000004141732,0.003129987,0.000077648874,0.0025871212,0.000010457288,0.000004476655,0.000019418401],"genre_scores_gemma":[0.45238096,0.54446125,0.00016770179,0.0028790245,0.000028662396,0.00007367771,0.0000011956635,0.00000470275,0.0000028472327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692196,0.0007483163,0.0015205693,0.00035471027,0.00027024222,0.00018422326],"domain_scores_gemma":[0.99814457,0.0007217454,0.00042297997,0.00035474237,0.00023971465,0.000116229385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020355461,0.00015948847,0.0015291342,0.00005202276,0.000038772458,0.0000016313885,0.00017505632,0.000049860937,0.000053813204],"category_scores_gemma":[0.0044403267,0.00009060733,0.00018655346,0.00028943064,0.0010130808,0.000043267315,0.0003092907,0.0002837498,2.5894582e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049735076,0.0004857538,0.7867337,0.16655806,0.00017067479,3.5937646e-7,0.000042706193,1.7524003e-7,0.0010001534,0.0000016917816,0.0010347224,0.04347466],"study_design_scores_gemma":[0.002133874,0.00008183053,0.62607735,0.37112948,0.00011768504,3.2119792e-7,0.000006540847,0.000019276778,0.00027541103,0.0000015772089,0.000115415656,0.000041229065],"about_ca_topic_score_codex":0.00004456061,"about_ca_topic_score_gemma":0.000009769969,"teacher_disagreement_score":0.20457143,"about_ca_system_score_codex":0.000017363112,"about_ca_system_score_gemma":0.00024112451,"threshold_uncertainty_score":0.5315807},"labels":[],"label_agreement":null},{"id":"W4415551402","doi":"10.1080/17512433.2025.2580349","title":"A review of current and emerging therapies in breast cancer: implications for older adults","year":2025,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Clinical trial; Breast cancer; Geriatric oncology; Alternative medicine; MEDLINE; Disease","score_opus":0.1191470631710012,"score_gpt":0.599206417123631,"score_spread":0.4800593539526298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415551402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002520206,0.97740495,0.000005896446,0.012442741,0.002092711,0.007413457,0.0005416366,0.000015661932,0.000080434445],"genre_scores_gemma":[0.0000013756735,0.9811967,0.00012074313,0.011360792,0.0009970175,0.0059788055,0.00025784096,0.000033241835,0.00005349374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994763,0.00067507464,0.003488329,0.0006605859,0.00010670259,0.00030626464],"domain_scores_gemma":[0.9952915,0.0022637295,0.0015633382,0.00034853801,0.00037303005,0.00015991932],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011458149,0.0004542131,0.006786973,0.00019830813,0.00002878855,0.0000014204043,0.00026605203,0.00023642482,0.0009271787],"category_scores_gemma":[0.00024793023,0.0003241426,0.0014101887,0.0005226903,0.00023613629,0.000035322842,0.0001234368,0.00052178133,0.000001844809],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006454617,0.00045416903,0.000073712916,0.40859133,0.00034555423,6.9607506e-7,0.000013087544,1.435138e-9,4.0430663e-7,0.000012418576,0.11046564,0.47997844],"study_design_scores_gemma":[0.0015828427,0.000093408176,0.00016052037,0.4448753,0.0029918058,0.000015222972,0.0000012655513,3.9432337e-7,5.1888276e-7,0.0000041602284,0.55016106,0.00011351989],"about_ca_topic_score_codex":0.000025127876,"about_ca_topic_score_gemma":0.000003969932,"teacher_disagreement_score":0.47986493,"about_ca_system_score_codex":0.00009603979,"about_ca_system_score_gemma":0.0013754864,"threshold_uncertainty_score":0.9999861},"labels":[],"label_agreement":null},{"id":"W4415803870","doi":"10.1080/17512433.2025.2585448","title":"Drug-drug interactions in anticoagulant therapy: a focus on oncology patients","year":2025,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Context (archaeology); Pharmacy; Anticoagulant; Venous thromboembolism; Dabigatran; Focus (optics); Cancer; Anticoagulant therapy","score_opus":0.07158266839678182,"score_gpt":0.5203596241519342,"score_spread":0.4487769557551523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415803870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56133926,0.11408788,0.000036275662,0.19956188,0.019397939,0.006785957,0.0000131052975,0.00010533648,0.098672375],"genre_scores_gemma":[0.50057536,0.3981196,0.00018822362,0.09988549,0.0004228033,0.00029167157,0.000015045099,0.000014088096,0.00048769164],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99698603,0.00066244544,0.0015384353,0.00038913594,0.00016590643,0.00025801963],"domain_scores_gemma":[0.99798065,0.001135714,0.0003402356,0.00029190237,0.0001420348,0.00010943036],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001041121,0.00018158414,0.001721336,0.0001916526,0.000032004074,0.000002455299,0.00019330127,0.000053999807,0.001106642],"category_scores_gemma":[0.00043106076,0.0001354211,0.00036066995,0.00027870873,0.00013342095,0.00003832674,0.00011596098,0.0004598384,0.000071038594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039217612,0.0103390375,0.010764301,0.0008750258,0.00030521295,0.0000354735,0.00012226777,7.846069e-7,0.00011592047,0.00044695023,0.68736476,0.28923807],"study_design_scores_gemma":[0.005611719,0.0006254288,0.0810229,0.004316133,0.00016369033,0.0000011965768,0.000031382042,0.000026503412,0.00090918405,0.00011527566,0.90706444,0.000112124035],"about_ca_topic_score_codex":0.00015243114,"about_ca_topic_score_gemma":0.000043860622,"teacher_disagreement_score":0.28912595,"about_ca_system_score_codex":0.00010323336,"about_ca_system_score_gemma":0.00020141613,"threshold_uncertainty_score":0.99980646},"labels":[],"label_agreement":null},{"id":"W4415833725","doi":"10.1080/17512433.2025.2585449","title":"A comprehensive systematic review of the types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class","year":2025,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deprescribing; Class (philosophy); Drug class; Polypharmacy; Alternative medicine; MEDLINE","score_opus":0.29893373787402444,"score_gpt":0.5729955539405893,"score_spread":0.2740618160665649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415833725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000018981066,0.9782706,0.000054831555,0.006468264,0.001218289,0.012786825,0.00013949914,0.000013740541,0.0010460847],"genre_scores_gemma":[0.00005297672,0.9719992,0.00016294724,0.026199477,0.00015326848,0.0011355035,0.00013126612,0.000023247343,0.00014211418],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9884467,0.0044618696,0.0058732256,0.00046090563,0.0005281096,0.00022917014],"domain_scores_gemma":[0.97436273,0.02010134,0.004097133,0.00079444406,0.00046706424,0.00017730807],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0038121631,0.0004043902,0.008439648,0.000081900376,0.000057942998,0.0000074221225,0.00073603744,0.00025324995,0.00028333155],"category_scores_gemma":[0.015181284,0.00019176371,0.0022926799,0.00058133405,0.0005970792,0.00006414496,0.00045151424,0.0008999351,0.000010347057],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084161686,0.00026217007,0.000003163777,0.86638033,0.0013258273,7.39488e-7,0.000018646115,3.5908716e-8,0.000008746453,0.00014521429,0.059155457,0.07261548],"study_design_scores_gemma":[0.0007123121,0.0000758601,0.0000032009855,0.51759565,0.010883381,0.0000071447416,0.0000101760215,0.0000044400017,0.000009718905,0.0000031672848,0.47061187,0.00008305452],"about_ca_topic_score_codex":0.000006918284,"about_ca_topic_score_gemma":4.4760878e-7,"teacher_disagreement_score":0.41145644,"about_ca_system_score_codex":0.000041644063,"about_ca_system_score_gemma":0.00045282548,"threshold_uncertainty_score":0.99311423},"labels":[],"label_agreement":null},{"id":"W4416742622","doi":"10.1080/17512433.2025.2596875","title":"Progress in the pharmacological management of vasovagal syncope","year":2025,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Vasovagal syncope; SAFER; Adverse effect; Clinical pharmacology; Blood pressure; MEDLINE","score_opus":0.04798331342320885,"score_gpt":0.498522488480167,"score_spread":0.4505391750569582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416742622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0805867,0.8173902,0.00014819429,0.03519286,0.0039534345,0.00422426,0.000004807149,0.00003753087,0.058461998],"genre_scores_gemma":[0.4718936,0.4882262,0.0010516219,0.037865505,0.00033089658,0.00036886559,0.000010415194,0.00001114412,0.0002417388],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971607,0.0006416035,0.0014603918,0.00030175905,0.00022722803,0.00020834846],"domain_scores_gemma":[0.99893665,0.00039640354,0.00023011421,0.00030434923,0.000081457634,0.000050995826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028128028,0.00014523692,0.001253488,0.00006764759,0.000017357988,0.0000020481202,0.00036838837,0.00009524568,0.00066583144],"category_scores_gemma":[0.00007676881,0.000088978486,0.0007684741,0.00041609516,0.00040054545,0.000027613813,0.0001456507,0.00031821092,0.000016582475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057223137,0.0028859142,0.0068931156,0.009297464,0.0024407853,0.00026683384,0.000062192856,0.0000018100446,0.00011932275,0.0010032008,0.25128174,0.7251754],"study_design_scores_gemma":[0.007929273,0.00040457508,0.049250174,0.006312518,0.0016112571,0.00002140612,0.00017586726,0.000054397206,0.0007503823,0.00006206832,0.9332787,0.00014942988],"about_ca_topic_score_codex":0.0000037711459,"about_ca_topic_score_gemma":2.8167707e-7,"teacher_disagreement_score":0.72502595,"about_ca_system_score_codex":0.000020904565,"about_ca_system_score_gemma":0.0001374934,"threshold_uncertainty_score":0.7290388},"labels":[],"label_agreement":null},{"id":"W7117151818","doi":"10.1080/17512433.2025.2609659","title":"Shaping future deprescribing priorities: outcomes of a World Café stakeholder workshop","year":2025,"lang":"en","type":"article","venue":"Expert Review of Clinical Pharmacology","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; University of British Columbia","funders":"","keywords":"Deprescribing; Stakeholder engagement; Stakeholder; Workforce; Bridge (graph theory); Enabling; Polypharmacy","score_opus":0.7589525289218272,"score_gpt":0.7529174369504285,"score_spread":0.006035091971398732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117151818","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.109810784,0.16244791,0.0024712023,0.6233081,0.057596374,0.011414934,0.00016603789,0.0002864148,0.03249823],"genre_scores_gemma":[0.049754582,0.13030317,0.005646939,0.8046434,0.0033112348,0.00081850786,0.00000860447,0.000035567653,0.0054780007],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98991954,0.0036363858,0.0049355323,0.0004518874,0.0003840186,0.0006726587],"domain_scores_gemma":[0.98170865,0.015550991,0.0015141206,0.00045967143,0.0005192781,0.000247282],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0074607837,0.0002071138,0.0017288044,0.00024484683,0.0002589205,0.0000026783412,0.0006310645,0.00019354574,0.004597701],"category_scores_gemma":[0.006976831,0.00016439814,0.00029872445,0.00097798,0.00031451465,0.0001554751,0.00033401157,0.0009948189,0.000045879424],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006609779,0.000118065,0.086387545,0.010967031,0.00013636907,0.000003100609,0.0020024206,6.952223e-7,0.00018764206,0.001302455,0.861365,0.03746353],"study_design_scores_gemma":[0.0017860007,0.000039134204,0.028327987,0.006393038,0.00006448889,2.6756547e-7,0.0012356236,0.0000167748,0.0000798399,0.000086198415,0.96183926,0.00013137823],"about_ca_topic_score_codex":0.00010438241,"about_ca_topic_score_gemma":0.00011972531,"teacher_disagreement_score":0.18133529,"about_ca_system_score_codex":0.0001033787,"about_ca_system_score_gemma":0.0018529498,"threshold_uncertainty_score":0.99631226},"labels":[],"label_agreement":null}]}